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Abstract
This research involves the design and fabrication of micro-scale electrodes and optimi-
sation of image reconstruction techniques. It aims to explore the use of bioimpedance
tomography techniques in extracting some structured information on three-dimensional
(3D) cell growth for the purpose of identifying cancer development, such as, cancer cell
spheroids. Electrical impedance tomography (EIT) is a non-invasive imaging technique
that maps the variation in conductivity of a sample, in the form of two or three di-
mensions. This technique has been successfully used in many clinical applications, for
example, in detection of breast cancer, acute stroke differentiation, detection of bleed-
ing due to traumatic brain injury, and detection of bacterial infection during surgery.
The capability of EIT to spatially map biological development process enables it to
be used in monitoring cell growth in three-dimensional formation. The work presented
in this thesis includes miniaturising the electrode designs from a millimetre-scale on
a PCB to a micrometre-scale on a glass substrate, and on a flexible material. Apart
from the fabrication and experimental work, sensitivity analysis was performed using
COMSOL Multiphysics® modelling. The final electrode design, the flexible micro-scale
electrode array (Flex-MEA), is fabricated on a flexible printed circuit board (PCB).
The development of Flex-MEA technology with improved imaging reconstruction on
micro-scale has produced an improved high-throughput and showed great potential as
a research aid in drug discovery. The research has proven that Flex-MEA enables im-
proved electrode arrangement compared with planar Pt electrodes making it a superior
choice as a portable, non-invasive technique to image the growth of microbial cultures.
Successful measurements of cell growth and proliferation propounded by this research
will have a definite potential not only in the biomedical field, example, in therapeutic
drug monitoring, but also in bioprocessing technology.
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This research focuses on the characterisation and monitoring of cell spheroids using
Electrical Impedance Tomography (EIT) to understand the behaviour and responses of
cells to internal or external environmental changes. The micro-scale electrodes fabricated
for this work use cell spheroids as the primary transducer to detect a change in
environmental or physiological conditions. In combination with EIT, the micro-scale
electrodes allow for fast, label-free, non-invasive quantitative measurements and are
sensitive to any changes in the environment and cell structures. This research optimises
the micro-scale electrode design to characterise and differentiate between cancerous cells
and non-cancerous (healthy) cells. The outcome of this work provides a foundation for
an enhanced cell spheroid analysis and characterisation, thus creating a way for earlier
cancer characterisation and monitoring while minimising healthcare costs.
CHAPTER 1. INTRODUCTION 2
1.1 Thesis Motivation
Early cancer diagnosis and treatment are the primary concerns throughout the world.
In 2012, 1.7 million new cases of breast cancer were diagnosed worldwide making this
disease one of the most common type of cancer among women [12]. The survival rate
is slightly higher in developed countries (75%) compared to patients in less developed
countries (65%) [12]. The enormity of cancer-related deaths is a result of late diagnosis
and the fact that cancer is a very challenging disease to be treated due to the non-
uniform nature of a cancerous tumour. None of the cancer types has similar malignant
or invasive potential. Thus, clinicians need to treat them uniquely [13].
It is essential to have a set of device and measurement techniques with enhanced
spatial resolution and high sensitivity. The development of a cost-effective and real-
time imaging system is vital in acquiring high fidelity images of cancer spheroids, which
involves the study of cell spheroids in image reconstructions of EIT. This research in-
vestigates methods to improve cancerous tumour detection and provide information
concerning cell spheroid characteristics through designing micro-scale electrodes and
optimising the image reconstruction techniques. It has a high potential for pharmaceu-
tical drug testing and could potentially assist the process of discovering new medications
to treat cancer.
1.2 Problem Statement
Successful development of the micro-scale electrodes for EIT will provide a means of
reconstructing images that differentiate non-cancerous cells and cancerous cells, other
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than quantifying biocompability studies. Anti-cancer drugs, like chemotherapy drugs,
require thorough characterisation and validation before they can be used clinically.
Methods like observation through inverted biological microscopes typically used for
observing organisms in a transparent flask and mass spectrometry imaging require the
cell spheroids to either be fixed or sliced before measurements and imaging to validate
the drugs. These methods are time-consuming and not being performed on living cells.
Real-time EIT can be used to improve qualitative measurements by identifying
specific time frames and drug concentrations, hence, eliminating redundant experimental
trials. Continuous EIT can capture the reactions of the cells towards an anti-cancer
drug at several points in time. Therefore, when a reaction is observed, quantitative
measurements are being performed at the specific time to probe for more information.
Apart from that, it also helps in obtaining fundamental information regarding cellular
responses and behaviour.
Repeatability, accuracy and spatial resolution are essential in successfully imple-
menting the image reconstruction of EIT of cell spheroids for cytotoxicity tests. Thus,
this research aims to address these problems through micro-scale electrode design opti-
misation, fabrication of 16-electrode arrays, and analysis of reconstructed images from
EIT experiments.
1.3 Thesis Objectives
This project is set out to explore the hypothesis that electrodes on the micrometre-scale
can, by obtaining relevant electrical properties of a cancer spheroid:
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(1) develop a Flexible Micro-scale Electrode Array for cancer cell detection,
(2) analyse the characteristics and modelling of cancer cell spheroids conductivity in
Flex-MEA, and
(3) evaluate the effectiveness of Flex-MEA in cancer cell detection and anti-cancer
drug efficacy.
1.4 Thesis Structure
Chapter 2 of the thesis provides background information on mammalian cells, the
difference between a Two-dimensional (2D) and Three-dimensional (3D) cell culture,
the applications of cell spheroids in the biopharmaceutical field and the cell culturing
protocol.
Chapter 3 describes the applications of EIT in biomedical practice including
measurement and image reconstruction techniques.
Chapter 4 defines the primary method implemented in realising this research that
is Finite Element Modelling (FEM) and simulations where the micro-scale electrode
designs are simulated to determine the most sensitive micro-scale electrodes. It also
describes the measurement patterns of an EIT technique.
Chapters 5 and 6 explore the design of biocompatible electrodes and presents
biocompatibility tests on passivating materials. The electrodes were initially fabricated
on a Printed Circuit Board then scaled down to micro-scale electrodes on glass substrates
and flexible material. These chapters also describe the EIT experiments for in vitro
characterisation performed on mammalian cell spheroids and 3D microbial cultures.
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In Chapter 7, conclusions, future developments and outlook of this research are
discussed.
1.5 Contribution to Knowledge
The contribution to the knowledge of this research was both in electronics and
biomedical applications. It further progressed the on-going investigation in the field
of bioengineering and drug discovery.
The novelty of the research was the implementation of EIT for image reconstruction
in microscale. The Flexible Micro-scale Electrode Array was placed in a Corning®
spheroid 96 well microplates enabling real-time monitoring of the MCF7 spheroids. The
Flex-MEA technology developed when integrated with improved image reconstruction
technique on micro-scale gives high throughput in basic research which aids in drug
discovery.
The outcomes of this research, which include the measurement of cell growth and
proliferation, and influence of resistance variation towards image reconstruction, are
valuable in monitoring the effectiveness of anti-cancer drug therapies. It has potential
impact in pharmaceutical and biomedical engineering particularly in therapeutic drug
development.
Chapter 2




The method of growing cells under controlled conditions, generally outside of their
natural environment is called cell culturing. Although cell culture conditions vary for
each cell type, artificial environments mimicking the natural environment consist of a
suitable flask containing “culture medium”, an aqueous solution, that supplies amino
acids, carbohydrates, vitamins and minerals, which are the essential nutrients for cell
growth and proliferation. The culture medium also provides growth factors, hormones,
and dissolved gases such as carbon dioxide and oxygen [14]. The culture medium
normalises the physical and chemical environment which are the pH buffer, osmotic
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pressure, and temperature. Depending on the cell type, cells require a surface to attach
to for adherent or monolayer type of culture, or they grow free floating in the culture
medium, known as a suspension culture.
All living things are composed of at least one cell [15]. Cell biology is a study of cell
structure and its function, which involves the concept that cells are the basic unit of
living things [16]. Cells make up the entire human body, and in each cell, there is a
set of instructions, the deoxyribonucleic acid (DNA), that instructs the cell when to
reproduce and die [17].
Cell is the smallest structural and functional unit of all living things [18]. Cells are
made from nucleic acids that help expressing the genetic code, proteins, carbohydrates,
and lipids which are the components of cell membranes [19]. Figure 2.1 illustrates the
structures of an animal cell composing of nucleus, cytoplasm, cell membrane, DNA,
mitochondrion, endoplasmatic reticulum, lysosome, ribosome, and Golgi apparatus.
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Figure 2.1: Illustration of the structures of an animal cell [1]
Since the human embryonic stem cells (hESCs) are proven for drug and toxicity
screening and the human stem cell models complement conventional animal models,
its implementation reduces costs and the use of animal models in drug discovery [20].
Cellular models have been used to study the therapeutics in neurodegenerative disorders
[21], develop antiatherosclerotic therapy [22], and perform drug screening for toxicity
assessments [23].
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2.2 Importance of cell culture
Research in tissue engineering, stem cells and molecular biology primarily involves
culturing cells on flat plastic or glass dishes. From today’s advances of polymer
technology, the standard plastic dish for 2D cell culture commonly used in the
laboratory. This is known as the Petri dish, with its name being taken from Julius
Richard Petri, a German bacteriologist [24]. Many researchers today also culture cells
in laboratory flasks, conical flasks, and disposable bags like those used in single-use
bioreactors. Other than Petri dishes, scientists have long been growing cells within
biologically derived matrices such as collagen or fibrin, and more recently, on synthetic
hydrogels such as polyacrylamide or polyethylene glycol (PEG) [25].
Cell culture in three dimensions has been called “Biology’s New Dimension” by
Alison Abbott [26]. At present, the practice of cell culture remains based on varying
combinations of single or multiple cell structures in 2D [27]. Currently, there is an
increase in the use of Three-dimensional (3D) cell cultures in research areas not limited
to drug discovery, cancer biology, regenerative medicine and fundamental life science
research. There are a variety of platforms used to facilitate the growth of 3D cellular
structures including scaffold systems such as hydrogel matrices [28], solid scaffolds,
scaffold-free systems such as low adhesion plates, nanoparticle facilitated magnetic
levitation [29] and hanging drop plates [30].
As the natural extracellular matrix (ECM) is vital in the survival, proliferation,
differentiation and migration of cells, different hydrogel culture matrices mimicking
natural ECM structures are potential approaches to in vivo like cell culturing [25].
Hydrogels are made from polymers [31] or natural source for example, agarose [32].
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They are composed of interconnected pores with high water retention, which enables
efficient transport of substances such as nutrients and gases.
The 3D cell culturing using the magnetic levitation method (MLM) is a technique
of growing 3D tissue by inducing cells treated with magnetic nanoparticle assemblies
in spatially fluctuating magnetic fields. By applying neodymium magnetic drivers, this
technique promotes cell to cell interactions by levitating the cells up to the air or liquid
interface of a standard Petri dish [33]. The magnetic nanoparticle assemblies consist of
a blend of magnetic iron oxide nanoparticles, Gold (Au) nanoparticles, and the polymer
polylysine. 3D cell culturing is scalable, with the capability to culture 500 to millions
of cells using single dish to high-throughput low volume systems.
One of the most common methods of creating 3D cell cultures is to process them into
spheroids. 2D cells are cultured until they are 90% confluent before spheroid processing
in round-bottom ultra low-adhesion plates. With the intention to allow cells to form
aggregates in suspension, the cells need to be cultured in a condition, which prevents
them from adhering to a solid surface. Commercial round-bottom well plates with low
attachment surfaces for single spheroid production per well are available from Corning®
and the cell concentration determines the processed spheroid size [34].
2.3 Basics of cancer
Cancer begins when a healthy cell becomes damaged and starts to multiply out of
control. Cancer cells become less dependent on signals from other cells, making them
resistant to the controls that maintain the growth and death of normal cells [35]. Figure
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2.2 shows the difference between cancerous and non-cancerous cells on an underlying
tissue.
Figure 2.2: Cancerous cells and non-cancerous cells on an underlying tissue
There are various types of cancer. Cancer can begin in any parts of the body;
lungs, breasts, colon, as well as blood. Cancers are similar in many ways, but they
have their own particular method of growing and spreading [36]. Figure 2.3 shows
the development of cancer, which happens when a single mutated cell proliferates
abnormally and multiplies that result in progression of the tumour [2].
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Figure 2.3: Stages of tumour development [2]
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2.4 Disease models
Disease models are a collection of cells that can be used as a model of an actual human or
animal disease [37] which are a vital implementation in understanding the mechanisms
that encourage the progression of a disease and aiding in developing novel therapies.
Transgenic animals or transformed cell lines are usually used in a disease model [38].
2.4.1 The 3Rs concept
The term “3Rs” refers to replacement, reduction, and refinement of the use of animals
in scientific research [39]. This concept is a robust framework to minimise the use and
suffering of animals and to deal with the harm to animals. This concept reduces animal
suffering and leads to efficient scientific research [40]. According to the United Kingdom’s
national organisation for the 3Rs, the National Centre for the Replacement Refinement
and Reduction of Animals in Research (NC3Rs), the standard definitions are described
as:
• Methods which avoid or replace the use of animals in research (Replacement),
• methods which minimise the number of animals used per experiment (Reduction),
and
• methods which minimise animal suffering and improve welfare (Refinement). [41]
2.4.2 New drug discoveries
Drug discovery is the procedure of finding new drugs and introducing them to the
market for patients or clinicians [42]. The drug development and drug discovery process
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involves target validation, finding the right potential drug to interact with the selected
targets, performing laboratory and clinical trials on the new compound to ensure its
safety and effectiveness, and finally attaining approval for new drugs to be used as new
therapies [43].
Figure 2.4 illustrates the development process in biopharmaceutical research [3].
This is a time-consuming process consisting of pre-clinical research and clinical trials
that involve not a small number of volunteers but thousands of volunteers and chemical
entities to deliver a single Food and Drug Administration (FDA) approved medicine.
Figure 2.4: The biopharmaceutical research and development process from discovering a drug
to getting it approved by the FDA [3]
2.5 3D cell culture versus 2D cell culture
It has been well known for over thirty years that cells grown using a 3D cell culture
technique are the most appropriate representation of natural tissues and organs when
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compared with cells grown in 2D environment. In a 2D cell culture, cells are grown on flat
dishes made of synthetic polystyrene plastic that is very stiff surface. The cells adhere
and spread on this plastic surface and form unnatural cell attachments to proteins that
are deposited and denatured on the synthetic surface [44].
In 3D cell culture, cells attach to one another and form natural cell-to-cell
attachments. They are flexible and elastic like real tissues. Cells are typically surrounded
by a matrix of complex proteins in their native configuration, and this provides
important biological instructions to the cells. In a 3D cell culture environment, cells
can exert forces on one another, and move and migrate as they do in vivo. These cell-
cell interactions in 3D cultures also include gap junctions, which directly couple one cell
to another.
Gap junctions are much more common in 3D than 2D cell cultures. They enable
cells to communicate with one another through exchanging ions, small molecules and
electrical currents. The proximity of cells in a 3D environment enables surface adhesion
molecules and surface receptors on one cell to bind to similar features on an adjacent
cell [45]. This coupling in the 3D environment also maximises the cell-cell communication
and signalling that is critical for cell function [46]. The phenotype of cells grown in 3D
is more complicated and exhibits more physiological relevance to natural tissues than is
the case with 2D cells. For instance, liver cells perform liver organ functions in 3D cell
culture where as 2D cell culture do not. Cartilage cells form more differentiated cartilage
tissue in 3D cell culture compared with 2D cell culture, and the cell type continues with
almost all cells of organs and tissues. A scaffold-based 3D culture is commonly used for
tissue regeneration of the bone, cartilage, skin, vascular or skeletal muscle [47].
A tumour spheroid has a necrotic core, a quiescent zone which slowly proliferates
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or does not proliferate depending on the availability of nutrients and oxygen, and a
proliferating zone, where the cells rapidly growing. Figure 2.5 is a microscope image of
an MCF7 spheroid which shows the necrotic core, proliferating and quiescent zones.
Figure 2.5: Microscope image of an MCF7 spheroid
The benefits of 3D compared with 2D cell culture also manifest when mimicking
pathological conditions such as cancer. For example, breast cancer cells grown in a 2D
environment can quickly be killed by low doses of chemotherapeutic drugs or low doses
of radiation, making them less efficient for drug testing research. If the same cells are
processed in a 3D cell culture, they are resistant to the same doses of chemotherapeutic
drugs or radiation, precisely like cancerous tumours found in the body. Hence, cells
grown in 3D are more valid targets for testing and discovering new drugs to treat
cancer.
Another benefit of testing drugs in 3D cell culture is that 3D cells form multi-layers
of cells. In contrast, 2D cells form a monolayer of cells that are thinly spread on a plastic
surface. When performing drug testing on 2D cells, the drug diffuses a short distance
across the cell membrane to reach its intended target while for 3D cells, the situation
is more realistic and a drug needs to diffuse across multiple layers of cells to reach the
cells on the inside of a microtissue [48]. The diffusion across multi-layers of cells mimics
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the challenges found in the human body or in a cancerous tumour where a drug needs
to diffuse through many layers of cells and extracellular matrix (ECM) before it reaches
its intended target [49]. Moreover, cells grown in the 3D environment will form natural
barriers to drugs such as tight junctions that bind cells tightly together and slow down
the diffusion of drugs, thus making this a more realistic test.
It has been well established that cells processed into spheroids are much more
representative of the in vivo environment than 2D cell cultures. The multicellular
arrangement allows cells to interact with each other and the ECM provides a better
understanding of cellular complexities. Cancer and stem cell research are mainly focused
on areas where spheroids have substantial potential compared to 2D cell cultures.
In the 1980s Mina Bissell led a research group in Lawrence Berkeley National
Laboratory [50] which developed 3D culture techniques for in vivo models. Bissell
highlighted the importance of the ECM, its effects on gene expression and subsequent
effects on neighbouring cells, along with the crucial role of the microenvironment [51].
This research study has led to the rise of 3D cell culture over monolayer culture
techniques, and spheroids have become a standard tool for a range of applications,
from studying complex malignant tissues to therapeutics research.
Advanced techniques now permit researchers to study spheroids, sub-populations,
and individual cells in a colony. Spheroids first need to be generated, and this is where
careful attention must be paid to achieving an optimal culture environment. In addition
to the ECM, there are a number of other factors to control, including temperature, pH
and carbon dioxide, which can determine the viability and reproducibility of spheroid
generation [52]. Previous studies have identified ideal hypoxic conditions, and the range
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of specialised culture equipment and synthetic coatings that are now available have
made spheroid research increasingly accessible and versatile.
While previous research has set down the foundations of spheroid studies, the future
of the research area is likely to span across multiple clinical and research applications.
In particular, since spheroids can model tumours, it allows researchers to evolve more
robust drug discovery initiatives, which help to improve the understanding of cancer
treatments.
2.6 The applications of cell spheroids
2.6.1 The use of spheroids in cancer research
Cancer is one of the diseases most widely studied, but it continues to puzzle researchers.
The complex nature and behaviour of cancer cells make them very difficult to study.
Nevertheless, in present years, a multicellular tumour spheroid (MCTS) model has
commonly been adopted in cancer biology. The MCTS models provide an accurate
representation of the physiology of tumours, which gradually making an essential
contribution to our understanding of cancer biology [53].
Spheroids have numerous structural, functional and physiological resemblances to
tumours in vivo. Spheroids and tumours are both made up of heterogeneous cells and
have similar secretory and metabolic activity [54]. The environment in a 3D cell culture
exposes cells, enabling them to communicate with each other and their surroundings,
providing an optimal environment for the cells to respond in a similar manner to those in
a tumour [53]. Within such a representative environment, spheroids can express chemical
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gradients that is the difference in ions’ concentration across a membrane of the various
nutrients, oxygen and catabolites (a product of catabolism that breaks down complex
molecules into smaller molecules as part of the metabolism [55] found in a tumour, that
can aid drug development.
One of the most defining features of a tumour is its hypoxic core, as researchers
believe it is the reason for the failure of cancer drugs and treatments. This can be
replicated in spheroids [53]. As a tumour grows, the cells will often run out of adequate
blood supply, leaving the centre of a tumour with a low concentration of oxygen
and nutrients. In addition to this, the reproducibility and reliability of the developed
spheroid culture systems facilitates its adoption in cancer research.
2.6.2 Tissue culture and engineering
Cell culture is an essential component of tissue culture and tissue engineering. It forms
the basics of growing and maintaining cells in vitro. The primary application of human
cell culture is in the stem cell industry, where mesenchymal stem cells can be cultured
and frozen in vials (cryopreservation) for future use. Tissue engineering potentially
offers vast improvements in low-cost medical care for hundreds of thousands of patients
annually [56]. It involves culturing and growing cells in scaffolds, so, a non-invasive
and real-time monitoring of 3D cell culture will aid in monitoring the tissue growth in
scaffold-based tissue-engineered constructs.
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2.6.3 Vaccines
Vaccines for diseases like polio, measles, mumps, rubella, and chickenpox are produced
in cell cultures [57]. Novel ideas in the field of vaccines include recombinant DNA-based
vaccines, such as one made using human adenovirus that is a common cold virus as a
novel adjuvant [58] [59]. The discovery of new vaccines require careful assessments from
testing, licensing and monitoring [60]. A real-time non-destructive monitoring technique
of 3D cultures would be able to decrease the time taken for a vaccine to pass through
the stages prior to being licensed for use.
2.7 Tissue culture techniques protocol
There are three types of cell cultures; primary cells cultures, secondary cell cultures and
cell lines [61]. Primary cell cultures happen when the cells are isolated from the tissue
and proliferated until they reach confluence. When a primary cell culture is subcultured,
it is then known as a secondary cell culture. Subcultures or passages are formed by
transferring the cells from one culture vessel or flask, to the other [62]. A cell line can
be either finite or continuous depending on its lifespan in culture: whether it is limited
or immortal [61].
Adherent cells and suspension cells are the two types of the primary cell cultures.
Cells grow in a monolayer attached to the surface of a tissue culture dish or flask is
known as adherent cells. The cell growth is limited by the surface area of the culture
dish or flask on which the cells are proliferating. Since the adherent cells are attached
to the surface, the cells are dissociated through trypsinisation. Suspension cells do not
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attach to the surface but instead, the cells grow floating in the culture medium and the
cell growth is limited by the concentration of cells. The suspension cells do not need
any enzymatic dissociation as they are free floating in the culture medium. Cell lines
derived from solid tissue classified as epithelial, endothelial, fibroblast and neuronal are
adherent cell lines while cell lines derived from blood are suspension cell lines [63].
2.7.1 Culturing adherent cells
The technique of detaching confluent adherent cells from the vessel surface is known as
passaging the cells or trypsinising. Trypsinisation cut the bond between the cell and the
surface so that the cells no-longer adhere to the surface [64]. Mechanical scraping may
also be required to fully detach cells.
Plating density is the number of cells per volume of culture medium when adding
them to a cell culture vessel. It plays a critical role in the function of some cell types. For
example, a lower plating density makes granulosa cells exhibit estrogen production [65],
while a higher plating density makes them appear as progesterone-producing theca
lutein cells [66]. Cells can grow either in suspension or adherent cultures [67]. Some
cells naturally live in suspension such as cells in the bloodstream, which are clearly not
attached to a surface. Likewise, there are cell lines that have been adapted to be able to
survive in suspension cultures so they can multiply to a higher density than adherent
conditions would allow [68].
Adherent cells need a surface, such as a tissue culture flask coated with an
extracellular matrix component. The extracellular matrix components such as collagen
or laminin increase the adhesion properties and provide other signals required for growth
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and differentiation [69]. Most cells derived from solid tissues are adherent. An alternative
type of adherent culture is organotypic culture [70], which involves growing cells in a 3D
environment as opposed to 2D culture dishes. This 3D culture system is biochemically
and physiologically more similar to in vivo tissue [68] but is technically challenging to
maintain because of many factors, one of the examples, diffusion [71].
2.7.2 Maintaining cells in culture media
Most of the isolated primary cells undergo the process of senescence, and they stop
dividing after a certain number of population doublings while retaining their viability
[72]. This process is described as the Hayflick limit [73]. Cells are typically grown
and maintained in a flask such as that shown in figure 2.6. This is maintained at
an appropriate temperature and gas condition; 37◦C, 5% CO2 for mammalian cells
in an incubator. Culture conditions vary for every individual cell type, and variation of
conditions for a particular cell type can result in different phenotypes [74].
Figure 2.6: Cells are first cultured in a flat T25 flask [4]
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2.7.2.1 Growth conditions
Aside from pH, temperature and dissolved gas concentrations, the most common varied
factor in culture systems is the cell growth medium. Every cell growth medium recipe
has different values in pH, glucose concentration, growth factors and the presence of
other essential nutrients. The growth factors are often derived from the serum of animal
blood, such as fetal bovine serum (FBS) [75], fetal calf serum (FCS), equine serum, and
porcine serum [76] to supplement the media.
2.7.3 Manipulation of cultured cells
The common manipulations carried out on cultured cells are media changes, passaging
cells, and transfecting cells. These actions are performed using tissue culture methods
that rely on the aseptic technique. The aseptic technique aims to avoid contamination
by bacteria, yeast, or other cell lines [68]. Manipulations are typically carried out in
a sterile laminar flow cabinet to eliminate contaminating micro-organisms. Antibiotics
such penicillin and streptomycin as well as antifungals are added to the growth media
depending on the cell type [77]. As cells undergo metabolic processes, acid is produced
and the pH decreases. Hence, a pH indicator is added to the medium for nutrient
depletion measurement [68]. It is usually colourimetric and the culture medium in figure
2.6 will change its colour when nutrients in the media are depleted.
2.7.3.1 Cell passaging
Cell passaging, also known as subculturing, involves transferring a small number of
cells into a new vessel [78]. If cells are regularly split, they can be cultured for a
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longer time as it avoids the senescence-associated with prolonged high cell density [79].
Suspension cultures are easily subcultured with a small amount of culture containing
few cells diluted in a larger volume of fresh media. For adherent cultures, cells need
to be detached, and it is commonly performed with 0.25% w/v trypsin-EDTA [64] to
dissociate the cells. A small number of detached cells can be used to seed new cell
cultures [67].
2.7.3.2 Transfection and transduction
Another conventional method for manipulating cells involves the introduction of foreign
DNA by transfection [80]. It is regularly performed to cause cells to express a gene
of interest. More recently, the transfection of ribonucleic acid interference (RNAi)
constructs has been realised as a convenient mechanism for suppressing the expression
of a particular gene or protein. DNA can also be inserted into cells using viruses, in
methods referred to as transduction [81], infection or transformation. Viruses such as
parasitic agents are well suited to introduce DNA into cells, as this is a part of their
regular course of reproduction.
2.7.3.3 Cell storage
Cell lines in continuous culture are susceptible to genetic drift while finite cell lines are
fated for senescence [74] and cell cultures are susceptible to microbial contamination [82].
Since the replacement of an established cell line is time-consuming and it is a valuable
resource, it is critical to freeze them down and preserve for long-term storage [74].
Once a small excess of cells becomes available from subculturing, they should be
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frozen. The frozen cells will be the seed stock, protected, and not be made available
for general laboratory use [83]. Working stocks can be prepared and replenished from
frozen seed stocks [74]. If the seed stocks become depleted, cryopreserved working stocks
can then serve as a source for preparing a fresh seed stock with a minimum increase in
generation number from the initial freezing [84].
The ideal way for cryopreserving cultured cells is keeping them in liquid nitrogen in
a complete medium with a cryoprotective agent such as dimethylsulfoxide (DMSO) [74].
Cryoprotective agents lessen the freezing point of the medium and also allow a slower
cooling rate, substantially reducing the risk of ice crystal formation which can damage
the cells and cause cell death [85]. The typical temperature for cryopreservation of
mammalian cells is -80◦C.
2.8 Summary
Mammalian cell culture plays a vital role in research and development of new drugs and
is a heavy element in improving the quality of health and life of patients suffering from
life-threatening diseases such as cancer and genetic disorders. In fighting diseases, new
therapies or drug treatments are developed. When a new drug treatment is discovered,
it needs to be tested before bringing it to the market. A 3D cell spheroid represents
more physiologically relevant systems compared to 2D cell culture. Hence, cell spheroids
exhibit high potential for pharmaceutical drug testing.
This research is proposing a technique to avoid the implementation of animal testing
in an experiment. The technique also introduces a more time and cost-effective procedure
in the research and and development new drugs discoveries.
Chapter 3
Electrical Impedance Tomography
(EIT) in biomedical and clinical
applications
3.1 Introduction
Electrical properties such as the conductivity and permittivity determine the behaviour
of materials under the influence of external electric fields. Conductive materials have
a high electrical conductivity relative to the electrical current flow through a material,
which enables both direct and alternating currents to flow smoothly through them. In
contrast to that, dielectric (insulator) materials have a low conductivity.
Electrochemical impedance spectroscopy (EIS) has been known as a non-invasive
characterisation technique of tissue change [86] which can be used to analyse electrical
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processes occurring in a system. The technique is sensitive to changes in both surface
and bulk effects, which makes it a valuable technique for electrochemical research and
sensor applications. A reversible reaction at the working electrode is formed where both
the oxidised and reduced species are soluble in the aqueous solution at the electrode.
A complex impedance plot can be obtained by applying an alternating current to the
electrochemical cell.
In 1999, H.P. Schwan [87] published a historical overview on the application of
impedance measurement in biology. This technique began in 1911 when it was first
shown that erythrocytes (red blood cells) have an impedance that varies with frequency
due to the presence of cell membranes. The growth and activity of a cell, changes in
its structure, shape and location have all been monitored or measured in biosensors
using microelectrodes [88] where impedance characteristics of cultured cells are being
examined over a period of time.
An electrochemical sensing electrode is a transducer that converts between an
electric current in a wire to an ionic current in an electrolyte, i.e. tissue, and vice
versa. When designing and fabricating electrodes, it is crucial to consider the size and
the material used [89]. Stainless steel is a typical electrode material in dye-sensitised
solar cells (DSSCs) since it is resistant to corrosion [90]. Since Au is a biocompatible
material [91], Au-plated electrodes were implemented in a non-invasive bioimpedance
monitoring process of 3D cell culturing [92] and in a whole-cell biosensor for ECIS, the
cells were grown on Au-film electrodes [93]. Due to the biocompatibility demonstrated
in Platinum (Pt) [94], a glucose sensor based on Pt-electroplated carbon electrode was
developed to determine glucose in serum [95].
In an Electrical Impedance Tomography (EIT), measurements of the resistance be-
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tween different combinations of electrodes are used to determine the resistivity of an
object. Different regions the object that is under investigation have different conduc-
tivity. Therefore, current flow changes its direction, hence, making it possible to detect
the changes in boundary potential. The different tissue has different impedance. There-
fore, it is possible to differentiate their reconstructed images and detect physiological
changes.
3.2 Historical background of EIT
Tomography is an imaging technique that provides a cross sectional image through
an object using measurements performed on the outside of the object. It requires the
use of a penetrating wave, such as electromagnetic and ultrasonic which is affected by
the materials and structures that make up the oject. It normally involves performing
measurements of the absorption, reflection or emission of the measured waves at
different angles around the periphery of the object which can be used to reconstruct
the distribution of material properties in the cross section.
This technique has applications in the fields of biological [96] and physical sci-
ences [97]. In most cases, the production of these images is based on mathematical
tomographic reconstruction, often requiring significant computation. In a typical X-ray
tomography at a hospital, a sectional image is made through a body by moving the
X-ray source and the film in opposite directions during the exposure. Consequently,
structures in the focal plane appear to be sharper, while structures in other planes
are hazy. Different focal planes that contain the structures of interest can be selected
by adjusting the direction and extent of the movement. Prior to the introduction of
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more modern computer-assisted techniques, this technique which was developed in the
1930s by Alessandro Vallebona, a radiologist, proved useful in reducing the problem of
superimposition of structures in projection (shadow) radiography [98].
In 1953, B. Pollak described the use of planography, as another term for tomography
[99]. A chapter in the American Roentgen Ray Society’s 1996 book, “A History of
the Radiological Sciences” [100] provides a detailed history of the development of
conventional tomography from its inception until being replaced by computer-assisted
tomographic techniques starting in the mid to late-1970s. A computed tomographic
(CT) scanner was invented by Sir Godfrey Hounsfield who won the Nobel Prize in
Physiology of Medicine in 1979 [101]. It was a major advance in diagnostic medicine.
3.3 Biomedical and clinical applications of EIT
In recent years, Electrical Impedance Tomography (EIT) has been used to enable
early detection of cancer cells [102]. In particular, EIT has been used for detection
of breast cancer cells [103]. EIT is a fast, non-invasive, low-cost tomographic imaging
modality that generates cross-sectional or 3D images of conductivity and permittivity
distributions within the region of interest which does not involve radiation process. The
four main attributes in electrical properties of tissues are resistance (R), conductance
(σ), permittivity (ε) and capacitance (C).
In a biological tissue,R is an element that opposes the ions flow among its cells while
σ is the inverse of R. During the charging process of a capacitor when a supply voltage is
present, a charging current, i flows into the capacitor. The charging current is opposed
by any changes to the voltage across its conductive plates. The relationship between
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the charging current and the rate at which the capacitors supply voltage changes is as
shown in equation 3.1, where C is the capacitor capacitance value measured in farads





Frequency of the applied current affects the ease of current passage which means,
higher applied frequency leads to charges flowing through the object back and forth
rapidly. In a bioimpedance measurement, the opposition to current flow through a
capacitor, C, is known as reactance, X which measurement unit is similar to R that is in
Ohms (Ω). If a reactance value is high, the value of its effective resistance to alternating





In an EIT measurement, the tissue conductivity is determined by injecting current
through an electrode while measuring the electrode voltage(s). In the case of a breast
cancer, the malignant breast tumours demonstrate lower electrical impedance compared
to the healthy tissue [103]. A 3D EIT system for breast cancer detection in [104] also
mentioned that breast cancer tissue has lower impedance than the normal tissue.
This technique implemented by EIT can produce images by identifying the electrical
conductivity distribution of the test sample. High temporal resolution in 2D or 3D
images can be produced by the EIT technique [105]. EIT has been implemented in cell
cultures and other medical diagnoses [106]. Examples of EIT application in biomedical
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and chemical use are to detect breast cancer in a study conducted by Cherepenin [107]
and monitor brain function [108].
The EIT group at Oxford-Brookes University developed an EIT system wrapped
around the chest; wired then unwired for a 3D EIT imaging of the chest as shown in
figure 3.1 and results in figure 3.2 showing low conductivity when there was no breathing
activity and simultaneous conductivity change during breathing, were published in [109].
Figure 3.1: EIT imaging of the chest using the OXBACT3 EIT system [5]
Figure 3.2: Reconstructed images of left: breath holding and right: breathing
[109]
In figure 3.3, electrodes were attached to a grapefruit which represents a child’s
head. Then liquid is injected into the grapefruit to mimic brain haemorrhage. This set-
up was exhibited at the London Science Museum to demonstrate the application of EIT
in detecting brain haemorrhage.
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Figure 3.3: EIT of the brain [6]
3.4 Theory
3.4.1 Electrical Impedance Tomography (EIT)
EIT is a technique that reconstructs the conductivity distribution of an inhomogeneous
(non-uniform) medium. An alternating current is forced between a pair of electrodes, and
the voltages between adjacent electrode pairs are measured. Conductivity distribution
is then estimated based on the calculated boundary voltages [105].
3.4.2 Measurement techniques
In EIT, measurements are made using a ring of electrodes surrounding the sample
being tested. In the most typical EIT method, a stimulating alternating current signal
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is forced between a pair of adjacent electrodes and the resulting potentials are sensed
between each of the other adjacent electrode pairs [106]. A 1.5 mA peak-to-peak current
is applied [106] between the first electrode-pair (E1-E2) to ensure a reasonable value of
the signal-to-noise ratio (SNR). If the applied current is too small, the response voltage
on the electrodes will be very weak. However, if the SNR can be improved, applied
current of smaller amplitude can be used in the EIT measurement.
An example of the structure is presented in figure 3.4. An alternating current (I)
was first applied between the first electrode pair (E1-E2) and voltage (V ) measurements
are acquired between neighbouring electrode pairs (E3-E4, E4-E5, . . . , E15-E16). The
measurement matrix is shown in Table 3.1. The stimulation or excitation electrodes are
then changed, and the method is replicated with the current applied between subsequent
electrode-pairs (E2-E3, E3-E4, . . . , E16-E1) for a total of 208 measurements made for
each frame [110].
Figure 3.4: Illustration of EIT measurement
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In a single frequency time-difference (TD) imaging, a pair of complementary
currents with a fixed frequency were forced between two adjacent electrodes on an
EIT device consisting 16 electrodes. Complementary currents means, two sinusoidal
currents on two adjacent electrodes were applied with 180◦ phase difference in every
measurement. Firstly, a measurement at time t0 is recorded as reference data, then
the voltage variation at time t1 with respect to the reference data is used for image
reconstruction [105]. The voltage variation is calculated as
∆V = Vt1 − Vt0 (3.3)





‖∆V − J∆σ‖22 + λH(∆σ) (3.4)
where H (·) is the regularisation function and λ is the regularisation factor [105].
Brown and Seagar (1987) suggested a method for EIT equipment with 16 electrodes
with the skip-m method where m is the number of the electrodes that determines the
gap between the current carrying electrode and measuring electrode [111]. A current of
5 mA peak-to-peak at 5 kHz is sequentially applied to the human body using a pair
of adjacent electrodes, and the method is repeated by applying a current between each
pair of adjacent electrodes to obtain a set of electric potential data [111]. Figure 3.5
shows the skip-0 method in EIT measurements where the blue lines are the current
applied and red lines are the voltage measured.
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Figure 3.5: Illustration of skip-0 method with 8 electrodes [7]
In contrast to Brown and Sugar, Hua, Webster and Tompkins [112] proposed a
different technique called the cross method. Current is applied between a pair of more
distant electrodes compared to skip-0 through two opposed electrodes as illustrated in
figure 3.6. Distinguishability is the crucial concept in comparing injection strategies.
It is the smallest conductivity change that can produce variations in the measured
electric potentials more substantial than the uncertainty level of the measurements in
the electrodes.
Figure 3.6: Illustration of skip-2 method with 8 electrodes [7]
An electrode is a transducer that converts an electric signal (electronic current)
in a wire to an ionic current in an electrolyte, containing cells [89]. Figure 3.7 shows
an equivalent circuit of the electrode-electrolyte impedance. It is considered that each
cell is expressed in an equivalent circuit, and the biological tissue is constituted. In
the case of a uniform living tissue, an equivalent circuit on tissue level is express by
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intracellular and extracellular resistances Ri, Re, cell membrane capacitance Cm, and
the bulk resistance of the electrolyte RB.
Figure 3.7: Equivalent circuit of the experimental set-up which include the biological system as
implied by the components [8]
In relation to the cell electrical properties, The features found in the cell are
electrically excitable. When a single cell is inactive, the inner part of the cell will be
generally negative. The outer part of a neurone cell will be positive and has electrical
properties. When there is a transmission of signal to other cells, the features in the
cell will start to excite through cell polarisation. During cell polarisation, the inner cell
membrane will be polarised with respect to the outer part of the cell. At this moment, the
negatively charged features in the cell will be attracted towards the positively charge
features which concentrate along the outer part of the cell. When this happens, the
cell is said to be polarised and there appears to be a potential difference between the
middle part and the outer part of the cell membrane. It is possible to measure the
potential difference between the inner part and outside part of the cell by recording the
potential difference. Figure 3.8 illustrates the reactions involved with regards to the cell
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polarisation which consists of four reactions; molecules attached to the cell membrane,
the return of a membrane cell to the cytoplasmic pool, cells transmitting signals to other
cells, and the cell migration. Contact impedance between the electrode and the tissue
has to be small and known, in order to design instruments and reconstruct impedance
images. An equivalent circuit is used as a model on the cellular level shown in figure
3.7.
Figure 3.8: Illustration of the reactions with regards to cell polarisation where (a) signalling
molecules attach to the cell membrane, (b) a membrane molecule returns to the cytoplasmic
pool, (c) transmission of signals to other cells, and (d) cell migration [9]
Materials and electrode size are the two essential factors to be considered in
electrode design. Electrodes made of the right materials and size are crucial to
interface between the instrument metal and the ionic conductors in the tissue. Silver
(Ag) electrodes coated with AgCl are the most commonly used for measuring the
electrocardiogram (ECG). Stainless steel is a conventional electrode material since
it does not corrode. Au and Pt are used in specialised applications due to their
biocompatibility [113]. Graphite is often added to plastic materials to make them
conductive due to its low cost [114]. Carbon electrodes will not introduce toxic products
when embedded in the body, which is not the case for some other metals [115].
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In addition to metals, electrodes can also be made from conducting polymers [116].
A natural polymer such as karaya gum needs NaCl and other chemicals to be added
to produce a conductive adhesive polymer. Their impedance value is suitable for ECG
electrodes, but the impedance is high when used in imaging. Polyvinylpyrrolidone is
an example of a synthetic polymer that is hydrophilic, elastomeric, water-insoluble
pressure-sensitive adhesive. It has been used as an ECG electrode despite its high
impedance value [89].
3.4.3 Image reconstruction techniques
In most cases, the production of reconstructed images is based on mathematical
tomographic reconstruction. In a 3D image reconstruction, algorithms with multi-
plane electrode arrangements have been applied to create more accurate reconstructed
impedance distributions [117] [118] [119]. It is recommended to implement planar
electrode placement such that 16 electrodes are placed in two rings of vertically aligned
electrodes with electrodes placed sequentially in each ring [120].
Fundamentally, EIT involves the solving of two problems: the forward problem and
the inverse problem. The forward problem determines the electrical voltage distribution
on the outermost surface of the object arising from the applied current pattern injection
and conductivity distribution [121]. On the other hand, the inverse problem is the
image reconstructing step for EIT. The purpose of the reconstruction algorithm is to
define conductivity distribution obtained from the electrical voltage measurement and
sensitivity matrix [122].
Among five of the popular image reconstruction algorithms are Linear Back-
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Projection, linear Landweber, linear conjugate gradients, linear regularised Gauss-
Newton and non-linear regularised Gauss-Newton. Linear Back-Projection (LBP) is a
simple and fast algorithm of image reconstruction besides being one of the most common
techniques used in electrical tomography [123]. It is regularly implemented for its fast
speed. However, it results in a low quality of the reconstructed image. Therefore to
attain a high-quality image reconstruction, an iterative image reconstruction algorithm
is applied, and the Landweber algorithm is one example [124]. It is based on the
linearisation of a normalised form of the problem. More specifically, the normalised
forward problem is approximated using a series of hyper-planes. The reconstruction
matrix used in LBP is found to be a ’weighted’ transpose of the linear operator (matrix)
that defines the linearised-normalised forward problem. The rows of this latter matrix
contain the information of the sensitivity maps used in LBP.
Theoretically, EIT defines the relationship between conductivity change, δσ, and
the potential difference, δV, within a detecting domain. This relationship can be written
as:
δV = Jδσ (3.5)
where J is the Jacobian (sensitivity) matrix of EIT.
The image reconstruction for EIT encompasses the calculation of conductivity
distribution when the current introduced is known and voltage readings are recorded.
Due to the intrinsic ill-posedness and ill-conditioned characteristic of the EIT image
reconstruction problem, the solution can be formulated as the following optimization
problem based on regularisation techniques:
δσλ = argminσ‖Jδσ − δV‖2 + λf(δσ) (3.6)
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where λ represents the positive scalar regularisation parameter and f is the regularisa-
tion function encoding prior constraint information.
3.4.3.1 Tikhonov Regularisation
Tikhonov regularisation is one of the most popular regularisation methods for solving
ill-posed inverse problems and has been applied to EIT image reconstruction. The
Tikhonov regularisation can be formulated as:
δσλ = argminσ‖Jδσ − δV‖2 + λ‖δσ‖2 (3.7)
Further, the solution above can be written as:
δσλ = (JTJ + λIT I)−1JT δV (3.8)
where I denotes the unity matrix.
3.4.3.2 Gaussian-Laplace Regularisation
Another commonly applied regularisation tool is the Gaussian-Laplacian method. Figure
3.9 shows the three popular Laplacian operators applied to a single pixel.
Figure 3.9: Convolution kernels to approximate Gaussian-Laplace second-order derivates
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In this work, the first operator, i.e., the second-order four connected region Laplace
operator, is adopted. Accordingly, equation 3.6 can be rewritten as:
δσλ = argminσ‖Jδσ − δV‖2 + λ‖Lδσ‖2 (3.9)
Further, the solution above can be written as:
δσλ = (JTJ + λLTL)−1JT δV (3.10)
where L is the second-order four connected region Laplace operator matrix.
3.4.3.3 L1 Regularisation
Over-fitting is a problem that occurs when a model contains a large set of data.
Regularisation is one of the techniques to avoid over-fitting, where it ‘pushes’ the
coefficients in. For example, vector, x , to set to be zero for many components and then,
reduces the vector size. L1 regularisation is applied to the model to reduce its size.
Hence, by implementing L1 regularisation, vector x becomes smaller (more sparse), as
most of the components are zeros.
Letting λ as the regularisation parameter, then equation 3.6 in section 3.4.2 can be
rewritten as:
δσλ = argminσ‖Jδσ − δV‖2 + λ‖δσ‖1 (3.11)
Equation 3.11 is solved iteratively based on the spectral projected gradient for L1
minimisation method [125].
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3.5 Summary
Live-cell imaging is an essential analytical tool in biomedical research and pharma-
ceutical laboratories. Live-cell microscopy involves a compromise between obtaining an
excellent image quality and ensuring the cells are in good condition. Hence, the spatial
and temporal resolutions in an experiment are often limited to avoid exposing the cells
to a high illumination intensity over an extended period. Electrical Impedance Tomog-
raphy is a promising technique for non-invasive, radiation-free monitoring technology. It
is widely relevant and safe for the patient, enabling continuous real-time monitoring of
electrical properties of the organ or tissue over extended periods of time. Even though
the principle of EIT has been known for over thirty years, there are ongoing research
projects and publications signifying its possible applications in clinical practice in recent
literature.
Since micro-bioimpedance tomography research has not been widely studied, in
order to close the gap in research, micro-scale electrodes were designed in this research
and prior to the fabrication, an FEM was performed and further described in Chap-
ter 4. From the results obtained in Chapter 4, the following steps were designing and
fabricating the micro-scale electrodes for micro-bioimpedance tomography. Detailed ex-
planation with regards to the methods are discussed in Chapter 5. Micro-bioimpedance
tomography were then being performed on MCF7 spheroids and microbial cultures using
the fabricated micro-scale electrodes. Results and analysis of the micro-bioimpedance
measurements are explained in Chapter 6.
Chapter 4
Finite Element Modelling (FEM) of
micro-scale electrodes
4.1 Introduction
The description of the laws of physics for space and time-dependent problems are
typically expressed in terms of Partial Differential Equations (PDEs) and, in most cases,
these PDEs cannot be solved using analytical methods. Therefore, an approximation
of the equations will usually be constructed based on numerous types of discretisations
[126]. The FEM is the dominant discretisation technique in structural mechanics [127]
and is a method for numerical solution of field problems that divides a structure into
multiple elements [128].
FEM is one of the vital computation tools in various engineering fields. In neural
engineering, the technique is beneficial to interpret recorded electrical bio-signals
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generated by neural or muscle tissue activities [129]. In the electronics industry, FEM has
become known in the analysis of products subjected to impact loading due to producing
robust products by manufacturers [130].
4.2 Motivation of Modelling and Simulation
Modelling is a way to represent an actual system, and that includes both software and
hardware. If mathematical relationships drive the software components of a model, the
virtual representation can be computed under an extensive range of conditions to see
its behaviour [131].
The motivation for using FEM is to determine the influence of model parameter
on the solution by performing a sensitivity analysis [132]. The sensitivity analysis is
crucial in increasing model robustness, design optimisation, identifying parameters that
require further research, eliminating variables to simplify a model and providing a better
understanding of a model as well as variable interactions [133].
The FEM evaluates the optimum electrode layout and determines what is the
most effective micro-scale electrode morphology that can be made without affecting its
performance and the measurement efficacy. The types of FEM involved in this research
were 2D and 3D modelling. The 2D modelling identified which electrode tip morphology
gave the optimum performance and compared the simulation results with experimental
results. The 3D modelling was performed to study the sensor’s performance on cell
cultures since the ‘domain’ in a 2D simulation is the surface and not the volume. Hence,
simulations using cell spheroids had to be performed with the 3D model.
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4.3 Simulation models
The simulation models were created and analysed using COMSOL Multiphysics® and
the purpose of FEM is defined in figure 4.1 to obtain sensitivity distribution.
Figure 4.1: Process of the simulation models
4.3.1 Micro-scale electrode morphologies
Measuring voltage on an electrode separate from the current electrode minimises the
effect of contact impedance [89]. Four different micro-scale electrode morphologies were
proposed and presented in figures 4.2, 4.3, 4.4 and 4.5 to investigate which electrode
shape gives the finest imaging resulting in high-resolution images.
Figure 4.2: Square electrodes, length = 500 µm
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Figure 4.3: Rectangular electrodes, length = 500 µm and width = 250 µm
Figure 4.4: Circular electrodes, radius = 175 µm
Figure 4.5: Circular electrodes, radius = 250 µm
4.3.2 Simulation setup
The impedance of an artefact is dependent on the electromagnetic properties of the
material composing it. Material properties related to impedance are:






The COMSOL Multiphysics® modelling involved used the AC/DC application
module with Electric Currents (ec) physics. Table 4.1 shows the material properties of
Phosphate-Buffered Saline (PBS) and Pt electrodes defined in the model.
Table 4.1: Material properties defined in COMSOL Multiphysics®
Materials Conductivity Resistivity Relative Relative
σ (S m−1) ρ (Ω m) permittivity permeability
εr µr
Phosphate-Buffered 1.78 0.5618 80 N/A
Saline (PBS)
Pt 8.9× 106 1.12× 10−7 1 1.000265
The boundary/domain settings were set as follows in COMSOL Multiphysics® as
shown in figure 4.6.
(1) Electric insulation (Fluid reservoir)
(2) Terminal (Electrodes)
(3) Ground (Point at 0,0)
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Figure 4.6: Graphical representation of the boundary/domain settings in COMSOL
Multiphysics®
An alternating current of 1.5 mA was forced between a pair of adjacent electrodes
(skip-0) at 10 kHz as described in 3.4.2. The electric potentials were measured between
adjacent non-current carrying electrodes. The method was repeated by applying a
current between each pair of adjacent electrodes. The MATLAB® scripting was
integrated with COMSOL Multiphysics® to swap between electrodes and sequentially
apply 1.5 mA AC.
In order to utilise LiveLink™ for MATLAB®, MATLAB® script (.m file) is gener-
ated from COMSOL Multiphysics® Save As option. However, the simulation file from
COMSOL Multiphysics® needs to be solved for a pair of the electrodes prior to saving
it as a model file for MATLAB®. In the source code example shown below, eNum de-
notes the number of electrodes that is 16, indexMap is the array of electrodes according
to the domain set in COMSOL Multiphysics®.
#Creat ing the e l e c t r od e index
eNum=16;
indexMap=[10 12 14 16 17 15 13 11 9 7 5 3 2 4 6 8 10 ]
#10 i s E1 and e l e c t r o d e po s i t i o n i s going upwards
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[ newnode , nodenum]=nodee i t ( 6 4 ) ;
for i =1:eNum
#Se l e c t i n g the exc i t ed e l e c t r o d e s
#cur rent e x c i t a t i o n 1
model . phys i c s ( ’ ec ’ ) . f e a t u r e ( ’ term1 ’ ) . s e l e c t i o n . set ( [ ] ) ;
#cur rent e x c i t a t i o n 2
model . phys i c s ( ’ ec ’ ) . f e a t u r e ( ’ term2 ’ ) . s e l e c t i o n . set ( [ ] ) ;
#cur rent e x c i t a t i o n 1
model . phys i c s ( ’ ec ’ ) . f e a t u r e ( ’ term1 ’ ) . s e l e c t i o n . set ( [ indexMap ( i ) ] ) ;
#cur rent e x c i t a t i o n 2
model . phys i c s ( ’ ec ’ ) . f e a t u r e ( ’ term2 ’ ) . s e l e c t i o n . set ( [ indexMap ( i +1 ) ] ) ;
In the for loop, each pair of adjacent electrodes (those carrying current) is sequentially
swapped.
Since current forcing electrodes are different from the electrodes measuring voltage,
sensitivity is the dot product of the electric fields of voltage electrodes and the current
electrodes. In COMSOL Multiphysics® modelling, each measurement point contains
data of [Ex(x, y), Ey(x, y)] where (x, y) is the Cartesian coordinate of a measurement
point, Ex is the electric field in x -direction and Ey is the electric field in y-direction as
shown in figure 4.7.
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Figure 4.7: Electric field in COMSOL Multiphysics® modelling
A 64 × 64 array pixels image was chosen in the research to display the reconstructed
images. Figure 4.8 illustrates a 64 × 64 array pixels made up 4096 pixels. From
4096 pixels, 3320 pixels represented the cross-section of the fluid reservoir, that is the
experimental boundary, while another 776 pixels are outside the boundary.
Figure 4.8: 64 × 64 array pixels was chosen in the research for image reconstruction of micro-
bioimpedance tomography
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In the following source code, each function has different roles in a simulation model.
#Ex i s e l e c t r i c f i e l d , x component
e f i e l d x=mpheval (model , ’ ec . Ex ’ ) ;
#Ey i s e l e c t r i c f i e l d , y component
e f i e l d y=mpheval (model , ’ ec . Ey ’ ) ;
#Returns the coo rd ina t e s o f the eva lua t i on po in t s
data1=e f i e l d x . p ;
data2=e f i e l d y . p ;
#Returns the i n d i c e s o f the mesh e lements at each eva lua t i on po int
nodenum=e f i e l d x . ve ;
#Gets e l e c t r i c f i e l d in x−d i r e c t i o n
e l e x ( i , 1 : length : ( nodenum))=mphinterp (model , ’ ec . Ex ’ , ’ coord ’ , data1 ) ;
#Gets e l e c t r i c f i e l d in y−d i r e c t i o n
e l e y ( i , 1 : length : ( nodenum))=mphinterp (model , ’ ec . Ey ’ , ’ coord ’ , data2 ) ;
CirS (k , :)=(−(dot ( e l e x ( i , : ) ’ , e l e y ( i , : ) ’ )+dot ( e l e x ( j , : ) ’ , e l e y ( j , : ) ’ ) ) ) ;
They are as described below:
mpheval #To eva luate the exp r e s s i on at a l l node po in t s
mphinterp #To eva luate exp r e s s i on s at ex t rac t ed data in co−o rd ina t e s
in data1 and data2
ec . Ex and ec . Ey #The e l e c t r i c f i e l d s in x− and y−components r e s p e c t i v e l y
CirS$ ( ) $ #A function that eva lua t e s the s e n s i t i v i t y
The function Cirs() that evaluates the sensitivity solves the dot product of the two
fields, elex and eley which expresses the sensitivity to conductivity changes.
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The electric fields simulated for all four types of micro-scale electrode are exempli-
fied in figure 4.9. The electrodes size in the FEM has the same size as the micro-scale
electrodes on glass substrate. The intensity of electric field between electrode 1 (E1) and
electrode 2 (E2) gives information with regards to the strength of the electric field at
the particular location. The electric field is greatest as the distance between electrodes
gets closer.
Figure 4.9: Electric fields for the micro-scale electrodes. Top left: circular electrodes, radius =
175 µm, top right: circular electrode, radius = 250 µm, bottom left: square electrodes, length
= 500 µm, and bottom right: rectangular electrodes, length = 500 µm, width = 250 µm
With the circular electrodes, each charge has no net force on then, because they are
in equilibrium since there is the same amount of charge on either side of the electrodes.
However, for square and rectangular electrodes, the charge is piling up at the edge of
the electrodes because in such way, it balances the forces on each charge. The electric
field is strongest on the edge of the electrodes because it is higher when the distance
between the edges is shorter.
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The shape of the electric field is defined by the shape of the electrodes and the
distribution of the electric field is affected by the geometry of the electrodes. Equally-
spaced micro-scale electrodes produce a uniform distribution of charges. The 175 µm
radius circular electrodes do not illustrate a strong electric field between E1-E2, un-
like the 250 µm radius circular electrode, 500 µm square electrodes and rectangular
electrodes. The charge accumulates at the edge of both square and rectangular elec-
trodes, resulting the strongest field at these areas. The best ones are the 500 µm square
electrodes and rectangular electrodes because they have the highest electric field.
Figure 4.10 illustrates the sensitivity evaluated by the source code previously de-
scribed in 4.3.2. The sensitivity distribution is normalised which means it is dimension-
less (without units). It reflects the relative change. Based on the sensitivity distribution,
the square and rectangular electrodes were giving the highest sensitivity, therefore, the
optimum electrode shape was either square with length = 500 µm or rectangle with the
dimension length = 500 µm and width = 250 µm.
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Figure 4.10: Sensitivity distribution and simulated voltage measurements for square electrodes,
length = 500 µm, rectangular electrodes, length = 500 µm and width = 250 µm, circular
electrodes, radius = 175 µm, and circular electrodes, radius = 250 µm
With regards to 3D EIT, a simulation study was performed to improve the
electrodes that are placed around a body surface and current patterns for 3D EIT [10].
This study was done on macro-scale electrodes in a 30 cm × 28 cm diameter. The
purpose of the study was to investigate different electrode morphology with various
measurement patterns. The configuration of two-layer planar electrodes produced
promising results which could lead to an improved image reconstruction in EIT.
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Figure 4.11: Left: Configuration of two-layer 16 planar electrodes in a 30 cm height and 28 cm
of diameter cylinder, right: simulation result of a two cylindrical test samples spanning the full
height of the cylindrical volume [10]
4.4 Summary
It can be observed that square electrodes (500 µm × 500 µm) and rectangular electrodes
(500 µm × 250 µm) show the highest normalised sensitivity on the electrodes. The
sensitivity is affected by the electric field that is a measure of electric force per unit
charge, (Vm−1). These electrodes experimentally exhibit similar result. In addition to
that, EIT measurement is affected by the placement of the fluidic chamber and possible
differences between electrodes. Depending on the fluidic chamber position, small changes
in media volume and interfacial electrode impedance will cause variation in voltage
measurements.
Chapter 5
Electrode design and fabrication for
micro-bioimpedance tomography
5.1 Introduction
This chapter presents the development of the micro-bioimpedance sensor design and
fabrication. Factors that are investigated include biocompatibility, electrode material,
electrode morphology, and resistance. This resulted in the development of nickel-gold
(NiAu) electrodes on Printed Circuit Board (PCB), platinum (Pt) electrodes on a glass
substrate and a gold (Au) micro-scale electrode array on a flexible PCB (Flex-MEA).
5.2 Electrodes design on a PCB
An initial electrodes design was implemented on a PCB with 16 electrodes in a ring.
The full PCB consists of four sets of electrodes with different designs for the electrode
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geometries. The electrodes were fabricated on a PCB with Copper (Cu) tracks with the
following designs:
• Circular electrodes, radius = 0.5 mm
• Circular electrodes, radius = 0.25 mm
• Rectangular electrodes, 1.0 mm × 0.5 mm
• Square electrodes, 1.0 mm × 1.0 mm
5.2.1 Electrode design on EAGLE version 7.6.0 and rapid prototyping
to produce Cu electrodes
The low-cost, rapid prototyping facilities available at the Scottish Microelectronics
Centre (SMC) were utilised to fabricate the electrodes on a PCB. Figure 5.1 shows the
PCB design for EIT measurement using EAGLE, an electronic computer-aided design
(ECAD) software with the fabricated PCB presented in figure 5.2. A fluid reservoir
shown in figure 5.3 was attached to the PCB using UV cured epoxy at which point the
system was ready for measurements.
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Figure 5.1: PCB design on EAGLE version 7.6.0 for EIT measurements
Figure 5.2: PCB fabricated using the rapid prototyping for EIT measurements
CHAPTER 5. ELECTRODE DESIGN AND FABRICATION FOR
MICRO-BIOIMPEDANCE TOMOGRAPHY 60
Figure 5.3: Side view of the fluid resevoir
5.2.2 Nickel (Ni) and Au electroplating for biocompatible electrodes
5.2.2.1 Introduction to general electrochemistry
Electrochemistry is the branch of chemistry that studies the relationship of electrical and
chemical effects [134]. Electrochemistry is the study of chemical reactions that involve
electron or charge transfer, reduction and oxidation. In an electrochemical experiment
where a working electrode and a reference electrode are immersed in a solution, the
potential difference between the reference and working electrodes is varied using an
external power supply as shown in figure 5.4. The electrochemical reaction occurs at
the working electrode while the reference electrode has a consistent and known electrode
potential.
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Figure 5.4: Schematic diagram of the electrochemical cell Pt/NiCl/Ag/AgCl attached to power
supply and meters (or a potentiostat) for obtaining a cyclic voltammetry (CV) curve
All potentials are measured with respect to a separate reference electrode in the
solution. The potential difference, V, can produce a current flow in the external circuit
because electrons cross the electrode/solution interfaces as electrochemical reactions
occur. The number of electrons is measured with regard to the total charge, Q, passed
in the circuit. Charge is expressed in the units of coulombs (C), where 1 C = 6.24×1018
electrons. The relationship between charge and amount of product formed is given by
the Faraday’s law ; that is, the passage of 96,485.4 C causes a reaction (e.g., consumption
of 1 mole of reactant or production of 1 mole of product in a one-electron reaction).
The current, i, is the rate of flow of charge (or electrons), where a current of 1 Ampere
(A) is defined as 1 C s−1. When the current is plotted as a function of the potential, a
current-potential (i vs V) curves results. Such curves are informative about the nature
of the solution and the electrodes and about the reactions that occur at the interfaces.
CHAPTER 5. ELECTRODE DESIGN AND FABRICATION FOR
MICRO-BIOIMPEDANCE TOMOGRAPHY 62
5.2.3 Aims of plating the electrode tips
Since Cu is easily corroded and is toxic to cells, Au of thickness 0.5 µm was electro-
chemically plated on the Cu electrodes to make them biocompatible. As Au does not
tarnish and is found to be nontoxic to cells [135]. The 3-electrode configuration shown
in figure 5.5 was used for the electroplating process, using a Pt mesh counter electrode
and an Ag‖AgCl‖KCl (3 M) reference electrode. Prior to Au plating, the electrodes
were coated with a thin layer of 0.2 µm of Ni as a barrier layer to avoid Au migration to
Cu. The amount of time required for the electroplating of Ni and Au varies according
to the shapes and dimensions depending on the area of electroplating to occur.
Figure 5.5: Schematic diagram of the 3-electrode configuration used in the electroplating process
Electroplating times and current density were studied to obtain a uniform elec-
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where:
d = thickness of the plated metal (Ni or Au) (cm)
ρ = metal density of Ni or Au (gm cm−3)
n = number of electrons to be transferred (from Ni2+ to Ni, n=2, and from Au+ to Au,
n=1)
F = Faraday constant; 96485 C mol−1
A = area of Ni or Au electroplating to occur (cm2)
j = current density of 20 mA cm−2 for Ni plating [136] 10 mA cm−2 for Au plating [137]
Aw = atomic weight of Ni, 58.6934(4) [138] or Au, 196.9665(5) [138]
5.2.4 Electroplating
5.2.4.1 Ni plating
The Ni-plating acts as a barrier layer to ensure no Au migration to Cu. The electroplat-
ing process was performed with the chemical composition of Ni-plating solution defined
in table 5.1.
Chemical Molarity (M)
110 gl−1 Ni(II) chloride hexahydrate –(NiCl2.6H20) 0.46
30 gl−1 Boric acid (H3BO3) 0.1
2 gl−1 Sodium saccharin –
0.1 gl−1 Sodium dodecyl sulfate (SDS) –
250 µl of 5% HCl to stabilise the pH –of the electrolyte between 2.9 and 3.0
Table 5.1: Chemical composition of the Ni-plating solution
The target pH of the Ni-plating solution was pH 3.0 and the electrolyte maintained
at a value between 2.9 and 3.0. The pH was kept constant by adding 250 µl of 5%
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hydrochloric acid (HCl) solution to the Ni plating solution with the concentration of
110 gl−1, 0.46 M. The Cu electrodes were being cleaned with 10% sulfuric acid (H2SO4)
prior to the electroplating process and Ni was deposited at a current density of 20
mA cm−2. The required electroplating time was calculated using equation 5.1 with the
atomic weight of Ni, 58.6934(4) [138] and a current density of Ni, 20 mA cm−2 [136] to
have a uniform layer of Ni on the electrodes. The process was then repeated for the rest
of the electrodes.
At the working electrode, reduction occurred and resulted in deposition of atomic
Ni, Ni0.
Ni2+ + 2e– Ni0 (5.2)
Figure 5.6 shows photos of the Ni-plated electrodes and figure 5.7 shows the
chronopotentiometry plots (an electrochemical technique where the current of the
working electrode is kept constant, and the resulting potential from Faradaic processes
occurring at the electrode is monitored as a function of time). After completing the
Ni electroplating process, the Ni-plated surface was cleaned with 10% H2SO4 as it is a
standard protocol of cleaning metal excess for 15 minutes before proceeding to the Au
electroplating process.
Figure 5.6: Microscopic images of Ni-plated EIT electrode designs, from left to right the
dimensions are as follows: radius = 0.5 mm (circular electrodes), 1.0 mm × 0.5 mm (rectangular
electrodes), 1.0 mm × 1.0 mm (square electrodes), radius = 0.25 mm (circular electrodes)
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Figure 5.7: Chronopotentiometry of Ni electroplating for circular electrodes with radius = 0.5
mm, 1.0 mm × 0.5 mm rectangular electrodes, 1.0 mm × 1.0 mm square electrodes, and circular
electrodes with radius = 0.25 mm
The chronopotentiometry process in figure 5.7 shows different potential changes for
four different electrodes when Ni plating was performed to coat a thin layer of 0.2 µm of
Ni. The electrode with largest surface area, 1.0 mm × 1.0 mm square electrodes, gave
the lowest potential change while the circular electrodes have higher potential change.
5.2.5 Au plating
The Au plating solution was purchased from SPA Plating Ltd. The required electro-
plating time to obtain 0.5 µm Au plating was calculated using equation 5.1 with the
atomic weight of Au, 196.966 569(5) [138] and a current density of 10 mA cm−2 for
Au plating [137] to have a uniform layer of Au on the electrode tips. The process was
repeated for the rest of the electrodes. The calculated current which varied according to
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Working electrode Electrode to be plated
Counter electrode Pt wire (mesh)
Reference electrode Ag/AgCl electrode
Software GPES
Software method Method > Potentiometry (Galvanostatic)
Table 5.2: Electroplating set-up
the geometry of the electrodes was applied to the electrodes during the electroplating
process.
The Au plating tank solution contains potassium cyanide (KCN) which produces
poisonous hydrogen cyanide gas when reacting with an oxidising agent [139]. Hence, it
should not be mixed with any active oxidising agent and care was taken not to mix it
with any other types of acid solution. The Au plating solution consists of 4 g Au in a
one-litre solution. The electroplating set-up is summarised in table 5.2.
At cathode, reduction occurred and resulted in deposition of Au0.
Au+ + e– Au0 (5.3)
The Au-plated electrodes and chronopotentiometry of the Au electroplating are shown
in figures 5.8 and 5.9 respectively.
Figure 5.8: Microscopic images of Au-plated EIT electrode designs, from left to right the
dimensions are as follows: radius = 0.5 mm (circular electrodes), 1.0 mm × 0.5 mm (rectangular
electrodes), 1.0 mm × 1.0 mm (square electrodes), radius = 0.25 mm (circular electrodes)
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Figure 5.9: Chronopotentiometry of Au electroplating for circular electrodes with radius = 0.5
mm, 1.0 mm × 0.5 mm rectangular electrodes, 1.0 mm × 1.0 mm square electrodes, and circular
electrodes with radius = 0.25 mm
The chronopotentiometry graph in figure 5.9 shows different potential changes for
four different electrodes when Au plating was performed to coat a thin layer of 0.5
µm of Au. Different electrode has different relationship between the electrode potential
(voltage) and time in the chronopotentiometry graph. Unlike Ni plating, the 1.0 mm ×
1.0 mm square electrodes has the highest potential change in voltage during Au plating.
A clamp was employed to hold the Ag/AgCl/KCl reference electrode firmly in place
as illustrated in figure 5.10. The electroplating process was performed in a Faraday
cage that shields the set-up enclosed from external electric fields. Although accurate
calculations were performed to obtain the desired electroplating times, there were some
minor defects in the Au coating on some of the electrodes.
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Figure 5.10: Experimental set-up for Au electroplating in a Faraday cage
Figure 5.11 shows the Au electroplating protocol on Cu.
Figure 5.11: Au electroplating procedure on Cu electrodes
5.2.6 Limitations of electrodes on PCB
Due to the millimetre scale sensing area of electrodes on a PCB, it is a challenge
using it for micro-scale phantoms, cell spheroids and tissue scaffolds which are a few
hundred micrometres in size. Cellular resolution with EIT requires the dimensions of
the electrode system to be scaled down. Therefore, the EIT device was scaled down by
microfabricating the electrodes on a glass substrate.
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5.3 Micro-scale electrode design on glass substrate
In this research, the proposed layout has 16 micro-scale electrodes arranged in a ring
surrounding a circular volume which will be imaged using these electrodes specifically
designed and fabricated for EIT measurements. The micro-scale electrodes morphology
used were 500 µm × 250 µm rectangular, 500 µm diameter circular, 350 µm diameter
circular and 500 µm × 500 µm square micro-scale electrodes. The diameter of the fluid
chamber attached to each set of sensor electrodes was 6 mm which is the size of a single
well in a standard 96-well-plate for cell culture.
5.3.1 Micro-scale electrode fabrication techniques
These micro-scale electrodes for cell culture studies were fabricated on a substrate
(glass or silicon) where a conducting layer (typically an unreactive metal such as Au
or Pt) was deposited and patterned followed by a passivation layer (Parylene C, silicon
dioxide or silicon nitride) deposited over the conducting layer. The fabrication process
is illustrated in figure 5.12, while figure 5.13 shows the layout of fabricated electrodes.
The passivation layer over the electrodes was patterned to expose the metal and to
define the microelectrode area [88].
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Figure 5.12: Schematic cross sections illustrating the micro-scale electrode fabrication process
Figure 5.13: 16 micro-scale electrodes with r = 250 µm circular in a ring pattern
5.3.1.1 Wafer cleaning
The substrate used for this research was glass due to its transparency enabling better
optical inspection of the cells. The glass wafer was cleaned in Piranha solution to ensure
the wafers are clean before commencing the microfabrication process in the cleanroom.
Piranha solution is a mixture of H2SO4 and hydrogen peroxide (H2O2) that is used
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to remove organic materials from the substrate. Since the mixture is a strong oxidising
agent, it will remove most organic materials, and will also hydroxylate most surfaces.
The mixture used in this research was three parts (210 ml) of concentrated H2SO4 and
one part (70 ml) of 30% H2O2. Peroxymonosulfuric acid (H2SO5), a highly oxidising
acid, is produced when H2O2 has a reaction on H2SO4 [140].
Extra care had to be taken while preparing Piranha solution since it is highly
corrosive. The mixture of H2SO5, H2O2 and H2SO4 that is corrosive and highly oxidising
can react vigorously with organic materials during the cleaning process which could then
lead to an explosion. Even when made with care, the resultant heat could increase the
temperature to over 100◦C. The substrate cleaning took 15 minutes after which the
substrate was rinsed with plenty of de-ionised (DI) water followed by nitrogen (N2)
drying.
5.3.1.2 Metal patterning
The photoresist used in this process was AZ nLOF® 2035 (negative resist for metal
patterning) from AZ Electronic Materials USA Corporation. The desired thickness was
1.2 µm and the spin speed was set to 4000 RPM. The substrate was then soft baked for
5 minutes at 90◦C, before being exposed to UV light for 25 seconds using a photomask
on a Karl Süss MA8 mask aligner. After this the glass substrate was placed on the
hotplate for one minute at 110◦C for a post-exposure bake.
The next step was to develop the photoresist using AZ 726 MIF developer, also from
AZ Electronic Materials USA Corp. The dish was agitated to develop the photoresist
for around a minute until all unexposed resist was removed. The metal deposition
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was performed by using electron-beam evaporation on an ANS cluster tool. 10 nm
of titanium (Ti) was deposited as an adhesion layer, followed by 100 nm of Pt.
MICROPOSIT Remover 1165 was used to strip the resist following the metal
deposition. The glass wafer was soaked for 10 minutes in MICROPOSIT solution. After
10 minutes, the MICROPOSIT solution was changed, and the wafer was left in the
new solution for at least one hour. It was left over an hour to ensure the remaining
metal was removed. After one hour, the wafer was rinsed with isopropanol (IPA) and
DI water. This step was repeated to ensure any tiny bits of metal on the glass wafer was
thoroughly removed. The wafer was then rinsed with IPA and DI water after one hour.
The glass wafer was cleaned in O2 plasma for 5 minutes before Parylene C coating the
passivation layer.
The microscopic images of the post-liftoff process are shown in figure 5.14.
Figure 5.14: Microscopic images of the post-liftoff process. From left to right; 175 µm radius
circular, 250 µm radius circular, 500 µm × 250 µm rectangular, and 500 µm × 500 µm square
micro-scale electrodes
5.3.1.3 Deposition of passivation layer
Parylene C was used as passivation, and 1.2 µm thick layer was deposited by physical
vapour deposition in a SCS Labcoter tool. For thickness measurement, a silicon (Si) chip
acting as a reference was placed together with the glass substrate during the deposition
process. The Parylene C coating thickness on the Si chip was then measured using a
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NanoSpec reflectometer metrology tool that measures the thickness of thin, transparent
films on Si.
The deposition of passivation layer has similar process as the metal patterning
that was discussed in 5.3.1.2. However, the photoresist used in this process was
MEGAPOSIT™ SPR™ 350. The substrate was soft baked for 5 minutes at 90◦C, before
being exposed to UV light for 5 seconds using a photomask which design is shown in
figure 5.15, on a Karl Süss MA8 mask aligner. After this the glass substrate was placed
on the hotplate for one minute at 110◦C for a post-exposure bake. Parylene C was
patterned and etched to expose the electrodes and to create contacts.
Figure 5.15: Micro-scale electrodes design on a photomask for Parylene C patterning. The red
tracks are passivated with Parylene C while the areas in black are etched to create contacts
when performing the EIT measurements
The microscopic images of the micro-scale electrodes following post-Parylene C
etching process are shown in figure 5.16.
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Figure 5.16: Images of micro-scale electrodes after Parylene C etching process. From left to
right; 175 µm radius circular, 250 µm radius circular, 500 µm × 250 µm rectangular, and 500
µm × 500 µm square micro-scale electrodes
5.3.1.4 Wafer dicing
Prior to dicing the glass substrate, it was coated with MEGAPOSIT™ SPR™ 350 to
protect the Pt electrodes during the dicing process. The sensors were diced and then
cleaned in acetone, followed by IPA and as DI water to remove the photoresist (SPR350)
coated prior to the dicing process. The sensors were then cleaned in O2 plasma for 15
minutes. Figure 5.17 shows the Pt electrodes on a glass substrate. The tracks were
designed in such way so they all have equal resistance. However, the issues with lift-off
process seen in figure 5.14 mean there are small variations. The issue can be improved
by cleaving the substrate and using the scanning electron microscope (SEM) to produce
the cross-section images of the substrate.
Figure 5.17: Pt micro-scale electrodes on a glass substrate
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5.3.2 PCB for Pt micro-scale electrodes connection
A PCB was designed to connect the Pt micro-scale electrodes to the EIT system. The
PCB design for the Pt micro-scale electrodes connection was performed using TARGET
3001!, standalone software for PCB layout [141]. Contact problem often arose during the
EIT measurements which were known to be caused by the Pogo pin on the socket. Since
there are four pieces of PCBs stacking up on top of each other, there were possibilities
that either one of the Pogo pin was not in contact with the electrodes hence, disrupting
the EIT measurements. The fabricated PCB is shown in figure 5.18
Figure 5.18: The fabricated PCB for Pt micro-scale electrodes connection
Therefore, a new adapter for the Pt micro-scale electrodes was designed, as shown
in figure 5.19 where the EIT device microfabricated on the glass substrate was soldered
directly on the PCB using thin wires.
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Figure 5.19: EIT device (Pt micro-scale electrodes) directly attached on the adapter PCB
5.3.3 Biocompatibility tests on passivation materials
Materials selection plays an essential role in the design of micro-scale electrodes for
micro-bioimpedance tomography. It has to be biocompatible as so not to have any
potentially harmful physiological effects [142] during in vitro characterisation in the
lab. The term ’biocompatibility’ was first mentioned in 1970 by R.J. Hegyeli (Amer
Chem Soc Annual Meeting abstract) and C.A. Homsy et al. (J Macromol Sci Chem
A4:3,615, 1970).
A passivation layer is a coating layer to insulate and act as a barrier to corrosion,
thereby preventing damage to the biological system in a biomedical application. It is
typically the covering layer of a microelectrode structure and therefore is usually exposed
to the biological system, so its biocompatibility is also important. Silicon nitride [143],
silicon dioxide [144], photoresist [145] and polyimide [146] [147], are materials commonly
used materials as passivation layers. Apart from selecting a passivation material based
on dielectric constant and dielectric strength [148], biocompatibility is crucial in cell-
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based biosensors. Biocompatibility studies were performed on insulation materials used
in this work: silicon nitride, silicon dioxide, and Parylene C. Three 2.0 cm × 2.8 cm chips
were diced from silicon wafers for cell adhesion experiments. These chips were coated
with either 1 µm of Parylene C (deposited using an SCS Labcoter), 1 µm of plasma
enhanced chemical vapour deposited (PECVD) silicon nitride or 1 µm of PECVD silicon
dioxide using STS Multiplex PECVD.
The coated chips were treated in an oxygen plasma (Barrel Asher) for five minutes
to clean surfaces. They were placed in 60 mm plastic Petri dishes before seeding with a
concentration of 2,250,000 cells ml−1 of MCF7 breast cancer cells. As a control, MCF7
cells were also cultured directly in a 60 mm Petri dish. All Petri dishes were incubated
for five days before comparing the cell viability of the different materials.
Table 5.20 shows that the Parylene C coating has the highest cell density compared
to silicon dioxide and silicon nitride, making it the most suitable passivating material
for MCF7 cells.
Figure 5.20: Optical images of cells after culturing: (left) silicon nitride (centre) silicon dioxide
and (right) Parylene C
The trypan blue cell viability protocol was followed to discriminate between viable
and non-viable cells. Trypan blue solution is a dye used to determine between live and
dead cells. The trypan blue solution was added directly to the trypsinised cell suspension
in a 1:1 0.4% trypan blue solution to the cell suspension. After 5 minutes, dead cells
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were stained. Cells cultured on silicon nitride have the lowest percentage of live cells
while Parylene C exhibits the highest rate of live cells as shown in figure 5.21.
Figure 5.21: Trypan blue staining test results with different passivating materials to test cell
viability. The error bars represent standard deviation
5.4 Flexible Micro-scale Electrode Arrays (Flex-MEAs)
design
The idea of the Flex-MEA is to create a 3D ring of electrodes to incorporate the EIT
with 3D cell structures. When electrodes are on the chamber wall, an electric field
is evenly distributed within the 3D cell structure in the chamber, hence, resulting in
precise sensitivity.
The dimension of the Flex-MEA used is 36 mm in length and 27 mm in width.
The Flex-MEA was fabricated by Merlin Flex Ltd on a polyimide with Au micro-scale
electrode array. The material stack-up of our Flex-MEA is shown in figure 5.22. The
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Flex-MEA is comprising 25 µm adhesive and polyimide with 18µm Cu. It is protected
with 12.5 µm polyimide coverlay and thickened in the Zero Insertion Force (ZIF) contact
area with additional polyimide to give a finished thickness of 0.3 mm. The general
thickness on the rest of the Flex-MEA is 0.0805 mm.
Figure 5.22: The material stack-up of a single layer flex with ZIF feature
The Flex-MEA used in this work was designed to ensure all pairs of electrodes gave
the same cell constant, K, which unit is cm−1 [149]. Cell constant is the ratio of the





It relates the conductivity of the sample, κ:
κ = GK (5.5)
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Therefore, when a homogeneous sample is probed, all pairs of subsequent electrodes
produce identical results. When measuring an inhomogeneous sample, the impedance
then gives a measure of the mean resistivity of the sample down to a depth equal to the
electrode spacing.
By maintaining the ratio between the interelectrode spacing, s, and the micro-
scale electrodes pitch, d, constant, all the micro-scale electrode pairs have the same cell
constant. The evolution of Flex-MEA started with millimetre-scale planar electrodes
fabricated on a PCB to micrometre-scale planar electrodes fabricated on a glass
substrate and now improved further by having an electrode arrangement on a flexible
material. With the improved Flex-MEA design, every electrode will have different
resistance due to variation in track lengths as shown in figure 5.23
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Figure 5.23: The Flex-MEA design
The dimension of each micro-scale electrode is 500 µm in length and 250 µm in
width. The lines and pads will be accurate in size to ±25 µm, resulting in 475 µm to
525 µm for the Au micro-scale electrodes and ranging between 675 µm to 725 µm for
the interelectrode spacing with 3 - 5% tolerance.
The electrode and track dimensions on the Flex-MEA are summarised in table 5.3.
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Micro-scale electrodes pitch, d 1200 µm
Interelectrode spacing, s 700 µm
Micro-scale electrodes length 500 µm
Spacing between long tracks 100 µm
Tracks pitch 200 µm
Table 5.3: Flex-MEA dimension
The fabricated Flex-MEA is shown in figures 5.24 and 5.25 from top and bottom
respectively. The flexibility enables it to be fitted in either the fluid chamber or
conventional multiwell culture plates.
Figure 5.24: Top view of the PCB
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Figure 5.25: Bottom view of the PCB adapter PCB when placed in a fluid chamber
Since we are dealing with small resistance measurement, an adapter printed circuit
board (PCB) has been fabricated to attain equal and precise resistance measurement
for all 16 electrodes. This is further discussed in 5.4.1.
5.4.1 PCBs to EIT system adapter PCB
The adapter PCB design for the PCBs was also performed using TARGET 3001!,
a standalone PCB layout CAD software [141]. Since EIT is a relationship between
conductivity variation, δσ and the potential difference, δV , in a sensing field, it is
essential to keep the resistance value across the PCB to the EIT system identical for all
the micro-scale electrodes.





[1 + α(T − 25)] (5.7)
where:
CHAPTER 5. ELECTRODE DESIGN AND FABRICATION FOR
MICRO-BIOIMPEDANCE TOMOGRAPHY 84
ρ = resistivity (ρCu = 1.7× 10−8 Ωm)
L = track length, m
W = track width, m
t = track thickness, m
T = temperature in Celsius, C
α = temperature coefficient in C−1
Since it is challenging in equalising the resistance on Flex-MEA due to the restricted
space, the width and length of tracks on the adapter PCB as shown in figure 5.26 have
been adjusted as to attain equivalent resistance for each micro-scale electrode.
Figure 5.26: PCB adapter PCB
It is important to keep the series resistance identical for all the electrodes on a
PCB. Table 5.4 shows the electrode calculated and measured resistance on flexible
PCB, adapter PCB and its total resistance with 10% – 22% percentage error.
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Since it was a low resistance measurement, a four-wire resistance approach was
implemented to reduce the effect of test lead resistance. With this approach, voltage was
forced through one of the test probes and current is measured through the sense probe
for each electrode. The various percentage error was presumably due to the fabrication
process to accommodate different values of length and width.
The adapter PCB was fabricated using standard PCB fabrication process shown
in figure 5.27. Firstly, the required circuit was designed and printed as 1:1 artwork onto
an acetate sheet using a laser printer. The Gerber file was imported to the computer
numerical control (CNC) machine for drilling of the PCB. At this stage, the machine
drilled all the holes on the photoresist coated PCB. The printed artwork was next
attached on the PCB for UV exposure. It is very vital to ensure that the board is fully
exposed during UV exposure. The exposure time taken was 100 seconds, and we had to
be careful of the timings. If the resist is not exposed for long enough, it will be difficult
to develop it all away.
The developer solution was prepared by mixing 50 ml of Mega Electronics 600-010
Seno 4006 to 950 ml parts of DI water to make a 1-litre solution resulting in a 19:1
mix. The temperature applied was ranging between 40◦C – 50◦C and the time taken to
develop the photoresist was 60 s.
The PCB was cleaned and washed under running water in between the processes.
It was then placed in the etching tank containing ferric chloride at 40◦C – 50◦C for 7
minutes. The process left the Cu tracks with photoresist on them that was stripped off
using PC155 resist strip solution for 5 minutes. The solution was prepared by mixing 1
litre of PC155 to 4 litres of DI water.
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The PCB was immersed in the tin plating solution for 5 minutes before it starts to
oxidise. The PCB was then immersed immediately in cold water and thoroughly rinsed
and wiped dry before they were ready for the experimental works.
Figure 5.27: Adapter PCB fabrication process
5.4.2 Fluid chamber and plate
A 6.4 mm diameter fluid chamber was designed and printed on a 3D printer mimicking
the dimension of a 96-well cell culture plate individual well. The fluid chamber was
fitted in a 40 mm x 25 mm x 3 mm acrylic plate, as illustrated in figure 5.28 to hold it
in place.
Figure 5.28: (Left): Drawing of arcrylic plate where the fluid chamber is attached at the centre
of the arcrylic plate. (Right): Photo of the chamber arcrylic plate
The equipment used to machine the parts was a 3-axis milling machine (XYZ SMX
3500). The finish was achieved using a 1.5 mm diameter end milling cutter ran at 4000
RPM (revolutions per minute). As acrylic is a soft material, a high RPM was required,
and the feed rate was 400 mmpm (millimetres per minute). The feed rate determines
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how quickly it will move on the X and Y axis to make the circle profile needed to fit
the fluid chamber.
5.5 Sterilisation technique
Sterilisation, especially for medical devices, is important to avoid any exposure to
infections [150] when the devices are in use. Therefore, before moving to perform any
experimental work, the PCB was placed in an autoclave and heated through pressurised
steam to decontaminate and kill all microorganisms including bacterial spores. The part
being exposed to steam at 121◦C for 15 minutes. EIT measurements were performed for
post-sterilisation test on a 27mm3 cube made from ABS, non-conductive material and 5
mm x 1 mm metal disc. PBS was used as a reference, and it seems that the sterilisation
method did not affect the PCB’s functionality as the reconstructed images shown in
figure 5.29 give the precise representation of the experimental set-up.
Colour bar in the figure represents resistivity. Since sensitivity is higher at the
electrodes, resistivity was observed to be lower at the centre of the fluid chamber where
an ABS cube was placed in, hence was unable to reconstruct the third edge of the cube
perfectly. The reconstructed image for metal disc after sterilisation however matches the
experimental set-up and represents a high conductivity value at the area in the fluid
chamber where the metal disc was placed in.




Figure 5.29: Reconstructed images for the post-sterilisation test performed on ABS cube and
metal disc
5.6 Summary
First micro-scale electrode design was fabricated on a PCB (millimetre-scale) for micro-
bioimpedance tomography of cell spheroids and 3D tissue cultures. The second electrode
design was scaled down to micro-scale electrodes on a glass substrate. These two designs
represent the planar electrodes. The final micro-scale electrodes design was fabricated
on a flexible PCB, proposing a different electrode orientation compared to the planar
electrodes.
The compatibility of PCB in a 96-well cell culture plate makes EIT measurements
CHAPTER 5. ELECTRODE DESIGN AND FABRICATION FOR
MICRO-BIOIMPEDANCE TOMOGRAPHY 90
of a cell spheroid possible in an individual well without having to transfer the spheroid
to a separate chamber. Apart from providing a time-efficient method, it prevents from
mishandling during the spheroid transfer. The post-sterilisation test shows the PCB






A medical standard compliant, compact, high speed, 3D multi-frequency Electrical
Impedance Tomography (MFEIT) system for real-time 3D biomedical imaging has been
developed by the Agile Tomography Group at the University of Edinburgh [151] and
is used in this research for the measurements of micro-bioimpedance tomography of
cell spheroids and microbial cultures. Several advanced features are implemented in
this system to enable high-performance impedance spectroscopic imaging. It contains
32 electrode interfaces, and the supported frequency range operates from 10 kHz
to 1 MHz. There is also a fully adjustable current source with current real-time
monitoring and emergency switch-off functions. A flexible switching scheme has been
developed to enable individual sensing strategies. Real-time 3D imaging software, Visual
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Tomography, has been developed for rapid 3D image reconstruction, data analysis,
visualisation and parametric configuration. The highest attainable signal to noise ratio
is 82.82 dB on a 16-electrode sensor, and the system can achieve up to 1014 frames per
second at semi-parallel data acquisition for a real-time imaging [151]. In semi-parallel
mode, the differential voltages between adjacent electrodes are simultaneously recorded
for each current carrying electrode pair [152].
6.2 Micro-bioimpedance tomography of in vitro character-
isation on cell spheroids on Pt electrodes
6.2.1 Experimental work
6.2.1.1 MCF7 cells culturing
MCF7 cells were cultured for micro-bioimpedance measurements and grown into cell
spheroids. These human breast cancer cells, which are adherent and typically cultured
while attached to a surface [153], are readily available in the Tissue Culture Lab, at
The University of Edinburgh. The complete culture medium for MCF7 contains 85%
Dulbecco’s Modiffied Eagle Medium (DMEM) high glucose, 15% Fetal Bovine Serum
(FBS), 1% 20 mM L-glutamine and 1% penicillin-streptomycin [154]. A high glucose
medium was used to stimulate the proliferation of MCF7 cells while FBS is the source
of natural growth factors and hormones needed for cell growth and proliferation. L-
glutamine, an essential amino acid, is included in the DMEM composition for the cells
to be cultured longer while penicillin-streptomycin is a mix of antibiotics added to
prevent any bacterial contamination.
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2D cells are cultured until they are 90% confluent prior to spheroid processing.
The medium starts changing its colour to orange usually after 48 hours, due to the
changes in solution pH the cultured cells consuming nutrients from the medium. Hence,
the flask medium was replaced with fresh medium to replenish the nutrients. The cell
culture medium had to be replaced twice a week due to the change in its pH value and
was changed when the cells were not yet confluent.
A T-25 flask requires 4 ml of medium. The old medium was removed from the
flask using a pipette and disposed into a beaker filled with Virkon®, a disinfectant
based on peroxygen compounds that has a wide spectrum of activity against bacterial
spores [155]. The flask was then filled with 4 ml of fresh medium. The flask was orientated
in a horizontal position in the incubator. When the cells had reached 90% confluency
rate as shown in figure 6.1, the splitting process then took place.
Figure 6.1: MCF7 cells at 90% confluency rate
Splitting involves lifting the cells from the surface and one way to do that is to use
trypsin. For a T-25 flask, 0.5 ml 0.25% w/v trypsin solution is added to 1.5 ml of fresh
growth media which makes up a 2 ml solution to detach the cells. For the splitting ratio
of 1:5, 0.4 ml of the growth media with cells were transferred to a new T-25 flask which
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was filled with 3.6 ml of medium before the suspension transfer that made up the 4 ml
of solution in the T-25 flask.
The ratio 1:5 is empirical for the lab and culture conditions. Basic rule of thumb is
splitting the cells in such a way that they will reach an ideal confluency or sub-confluency
by the time of the next split which typically every other day. However, splitting can
be performed in higher ratio which brings to less cells trypsinisation for example, twice
a week. In order to ensure the cells have regular proliferation, the cells need to have
normal population doubling with regular split as cells do not like to be too diluted and
over confluent.
For every individual cell culture flask after the trypsining process, the passage
number for the flask was increased by one, i.e. ‘P41’ if the cells were taken from the
flask labelled ‘P40’. Observation on the MCF7 cells after trypsining can be seen in figure
6.2 where the cells are rounded and suspended in 0.25% w/v trypsin solution.
Figure 6.2: MCF7 cells after the trypsinising process
However, there were times when the cell culturing did not work right as exemplified
in figure 6.3. A clump observed in the flask were presumed to be dead cells which were
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not proliferating after three days. The flask containing MCF7 cells had to be agitated
after they were trypsinised to avoid the same incident from happening again. This is
to ensure single cells in culture medium did not attach to one another and they were
non-adherent. When single cells were still attached to one another after trypsinisation,
this resulted the cells to form clumps.
Figure 6.3: Dead cells observed in the flask
6.2.1.2 Spheroids processing
Figure 6.4 shows the culture protocol of MCF7 spheroids. When the cell density
has reached 90%, the flask surface was washed with 1 ml PBS to remove as many
extracellular proteins as possible. The PBS was then removed, and the flask was filled
with 0.25% w/v trypsin solution to dissociate the cells. A single cell suspension had
been obtained when the cells were observed to be detached from the flask surface. The
cell suspension was transferred to a sterile 15 ml centrifuge tube and centrifugation took
place at 1,200 RPM for 5 minutes. The supernatant was discarded carefully, so the cell
pellet was not removed. The cells were re-suspended in 1 ml of fresh growth medium,
and 10 µl was taken out for cell counting using a Haemocytometer.
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Figure 6.4: Graphical representation of MCF7 spheroids culture protocol
To process MCF7 spheroids, 100 µL cell suspension was pipetted into a Corning®
spheroid 96 well microplates shown in figure 6.5. Because the spheroid microplate has
a round bottom and not a flat bottom, the cells are formed as spheroids as illustrated
in figure 6.6.
Figure 6.5: Corning spheroid 96-well Corning® spheroid microplate used in the spheroids
processing
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Figure 6.6: Illustration of the spheroid formation after 48 hours
Three cell concentrations were prepared; 60,000 cells ml−1, 120,000 cells ml−1 and
240,000 cells ml−1. 100 µl of cell suspension was dispensed to three wells of 96-well
Corning® spheroid microplate for each concentration. The spheroid growth for each
concentration is shown in the graph in figure 6.7.
Figure 6.7: The MCF7 spheroid growth (in size) for three cell concentrations, 60,000 cells ml−1,
120,000 cells ml−1 and 240,000 cells ml−1 over 72 hours
The spheroid microplate was placed in an incubator set at 37◦C with 5% CO2
and spheroid formation as well as growth was visually observed after 24, 48 and 72
hours. The MCF7 spheroids are at their stable growth condition after three days of
seeding. The spheroid size is determined using ImageJ where the microscope images of
MCF7 spheroids were analysed to define the spheroid diameter. For spheroids with non-
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spherical shape, the size is determined by taking the average length between different
points around the perimeter as described in figure 6.8.
Figure 6.8: Average length between different points are taken to determine the size of a non-
spherical spheroid
Figure 6.9 shows microscope images of spheroid formation from each of these
concentrations.
60,000 cellsml−1 (0.43 mm)
120,000 cellsml−1 (0.64 mm)
240,000 cellsml−1 (0.74 mm)
Figure 6.9: Spheroid formation and growth: 60,000 cells ml−1 (0.43 mm), 120,000 cells ml−1
(0.64 mm) and 240,000 cells ml−1 (0.74 mm)
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6.2.1.3 Viability tests
A viability test was followed using trypan blue. In this process, the medium in the flask
was discarded and washed with 1 ml PBS. The cells were then trypsinised with 0.5 ml
0.25% w/v trypsin solution and incubated at 37◦C with 5% CO2 for 5 minutes. With a
1:1 ratio of cell suspension to trypan blue, 0.5 ml 0.4% trypan blue solution was added
to the flask. Observation under a microscope was performed after 4 minutes. In a trypan
blue exclusion test, the dead cells took up trypan blue as shown in figure 6.10.
Figure 6.10: Trypan blue viability test
The trypan blue cell viability protocol was essential for biocompatibility tests for
passivating materials. Biocompatibility studies were performed on silicon nitride, silicon
dioxide, and Parylene C as previously discussed in section 5.3.3.
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6.2.1.4 Effects of sodium bicarbonate on cells proliferation
The cells available in the lab are usually cryopreserved by storing the cells at -80◦C. In
order to culture frozen cells, the standard protocol starts by thawing them then, pelleting
them by centrifugation at 1,200 RPM for 10 minutes before transferring the pellet into a
flask filled with growth medium from the centrifuge tube. Two different growth medium
were prepared to study the effects of sodium bicarbonate on cells proliferation. Both
flasks were kept in the 37◦C 5% incubator, and daily observation was recorded. The
standard complete MCF7 growth media consists of 85% DMEM from Sigma-Aldrich,
high glucose), 15% FBS, 1% penicillin/streptomycin, and 1% 20mM L-glutamine.
Flasks #1 and #2 have the same number of cells. On day 2, few cells were seen
attached to the surface of flask #1 before replenishing the growth medium. The cells
were proliferating but in minimal quantity. When the cells had reached 50% confluency
rate on day 5, the growth medium was renewed. The cell’s proliferation was observed to
be rather slow which could be caused by the cells having been frozen. The confluency
rate was 55% on day 6 and 60% on day 7.
The growth rate of MCF7 is low meaning which, the average doubling time is 48
hours. In addition to that, it is normal for frozen cells to double up their average time
as the cells are still in shock when transforming from a frozen to a typical environment.
The cells were 70%, confluent on day 8 and the flask was restocked with fresh growth
medium. As soon as the cells had achieved 80% confluency rate on day 9, the cells were
sub-cultured into three T25 flasks for further experimental work.
Observation on flask #2 shows the cells did not look healthy. However, the growth
medium was renewed and on day four after the cells were cultured, they seemed to look
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more like unhealthy cells. Very few cells were attached to the flask surface resulting in
an inadequate confluency rate even after five days.
Even though the growth medium in flask #2 contained sodium bicarbonate, this
should not significantly affect the cell proliferation as sodium bicarbonate is used as a
buffer to regulate pH. The observation made on day seven exhibits low cell proliferation.
Nevertheless, the flask was renewed with fresh growth media.
Different growth medium composition clearly affects cell proliferation. After 4-5
days, the cells in flask #1 reached 50% confluency. However, cells in flask #2 did not
seem to thrive. The cell’s proliferation for both conditions is shown in figure 6.11.
Figure 6.11: Cells proliferation with different composition of growth medium
6.2.1.5 Biological waste disposal
Without proper biological waste disposal, the hazardous material has the potential to
harm as it can spread disease, impact the water supply, and environment. Disinfecting is
one of the steps in biological waste disposal, and it is a process to decrease the number
of organisms where it will not be harmful to health. Tissue culture waste from the
experimental works was mixed with 3% Virkon solution to disinfect. The waste was
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left overnight before flushing the contents to drain with plenty of water. Disposable
containers were disposed of in the ‘Biological waste bin’ while reusable containers were
washed up for reuse. Bacterial culture, on the other hand, was collected in a 500 mL
Duran bottle. When the bottle is 75% full, it was autoclaved in an on-site facility.
Contaminated tissue culture plates and flasks were disinfected with 3% Virkon solution
for at least two hours before flushing the excess liquid to drain and disposing them in
the ‘Biological waste bin’. All used pipette tips were placed in either ‘Used pipette tips’
jar for sterilisation or ‘Sharps bin’ with orange-coloured lid for incineration. Used gloves
were placed in ‘Biological waste Bin’.
6.2.2 Regularisation methods in image reconstruction for micro-
bioimpedance tomography
Three regularisation methods - Tikhonov, Gaussian-Laplace and L1 - for the image
reconstruction of 700 µm diameter test samples are verified using 500 µm × 250
µm rectangular Pt electrodes. The performance of these regularisation methods are
compared based on the reconstructed images.
Calibration data was obtained from a homogeneous background (250 µL of PBS
of concentration 1X), and followed by a test sample with higher or lower conductivity.
Figure 6.12 shows the positions of the two test samples in relation to the microelectrodes.
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Figure 6.12: (Left) Higher conductivity (Cu metal) and (right) Lower conductivity (rubber) test
samples. The positions of the test samples are indicated with black rings
Figure 6.13 presents three recorded data sets for Phosphate-Buffered Saline (PBS)
and two test samples with different conductivity values. The voltage difference range
between 1 mV and 6 mV, and these graphs do not show large differences between
each experiment. The patterns are regular in relation to the electrodes. If the setup is
homogeneous, we should observe a regular pattern over 104 measurements. Therefore,
the dissimilarities and irregular peaks observed in figure 6.13 are believed to be caused
by the placement of the fluidic chamber and possible differences between the electrodes.
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Figure 6.13: (Black) Calibration data of PBS, (red) measurement data with higher conductivity
test samples, and (blue) lower conductivity test samples
Conductivity distribution is then estimated according to the potential variation
obtained, and from the information gathered, image processing of the test sample can be
implemented. Calculations are performed based on the voltage difference values acquired
and images are then reconstructed according to the three regularisation methods as
shown in figure 6.14.











Figure 6.14: Image reconstructions based on three regularisation methods, Tikhonov Regulari-
sation, Gaussian-Laplace Regularisation and L1 Regularisation (colour scale in Ωcm)
For a test sample with lower resistivity (higher conductivity), Tikhonov regular-
isation is unable to produce a high intensity image. Gaussian-Laplace regularisation
gives the closest representation of the experiment setup although the intensity is not
as high as L1 regularisation. Although the reconstructed image is very strong using L1
regularisation, errors also appear to be obvious. Ideally the background should not show
significant variation in the resistivity. However, the imperfect resistance is caused by the
manufacturing process of Au micro-scale electrodes. Similar for a lower conductivity test
sample, the best image reconstructed is produced by Gaussian-Laplace regularisation,
despite having lower intensity as compared to L1 regularisation as unwanted errors can
be seen clearly in the image reconstructed using this technique.
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6.2.3 EIT measurements on MCF7 spheroids using Au micro-scale
electrodes on glass substrate
In figure 6.15, the MCF7 spheroid shows a higher resistance compared to the reference
solution of MCF7 complete growth medium. The intensity changes are dependent on
the conductivity of the MCF7 spheroid and complete growth medium. The green areas
represent the conductivity of the media, a baseline measurement taken before the MCF7
spheroid is introduced. The scale is based on the visual spectrum with blue-violet colours
representing a higher resistivity than the media and yellow-red colours indicating lower
resistivity.
The quality of a reconstructed image from the EIT system can be defined by
comparing the reconstructed image with an actual experimental setup. The percentage
error was 2.67% where the comparison was performed on the reconstructed image
against the actual test setup. The length of MCF7 spheroid can be determined from
the size of the chamber, which was 0.71 mm. In the reconstructed image, this value of
resistivity represents the outline of the MCF7 spheroid image and the value is -0.15 Ω
m, where the minus sign denotes that it is conductive, from the resistivity colour scale.
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Figure 6.15: EIT imaging of MCF7 spheroids using micro-scale electrode arrays on a glass
substrate
With regards to the drug effect experiment on MCF7 spheroids, a Triton-X
(surfactant) solution was prepared by diluting 0.5% of Triton-X in complete standard
MCF7 growth media. 0.3 ml Triton-X solution was mixed in the chamber filled with a
0.71 mm MCF7 spheroid.
Figure 6.16 shows the effect of Triton-X on the MCF7 spheroid which size was 0.71
mm in diameter. After 1 hour 25 minutes, the spheroid was observed to be in the same
condition as the reference understanding that the cell is dead.
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Figure 6.16: Triton-X effect on 0.71 mm MCF7 spheroid
6.2.4 Analysis method
The reconstructed images of MCF7 permeabilisation through the usage of Triton-X is
shown in figure 6.17 and shows cell permeabilisation every 5 minutes where t in the
figure denotes time in minutes. Triton-X was introduced at t = 10 minutes and the
impedance magnitude, Z, measured in ω is increasing over time.
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Figure 6.17: Reconstructed images of Triton-X effect on 0.71 mm MCF7 spheroid over 85
minutes
At t = 10 minutes when Triton-X was introduced to the MCF7 spheroid, its
conductivity started to decrease. The impedance, Z, is observed to be at the highest at
t = 45 minutes and did not vary much until the end of the experiment, after 85 minutes.
The change in conductivity shows the MCF7 spheroid death over time when Triton-X
was introduced in the fluid chamber.
6.2.5 EIT measurements on MCF7 spheroids using Flex-MEA
The cell culturing protocol described in 6.2.1.1 was repeated to grow 5.0 × 106 MCF7
cells into cell spheroids. The cells were dispensed in the 96-well spheroid microplate.
Figure 6.18 illustrates the placement of Flex-MEA in the well of MCF7 spheroid and
3D microbial cultures. The Flex-MEA is then connected to the EIT system. There
is a connection between the EIT system and the computer monitor that displays the
reconstructed images.
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Figure 6.18: Complete experimental setup representing the Flex-MEA, EIT system, display of
the reconstructed images and 96-well spheroid microplate
The changes in the MCF7 spheroids were measured over five frequencies; 10 kHz, 30
kHz, 50 kHz, and 70 kHz. The minimal voltage obtained between measurement number
27 and 38, which was below 10 mV for all frequencies, was due to the poor connection
in the experimental set-up. From the graph in figure 6.19, it was shown that there is
no significant variation against frequency. At high frequency, the induced electric field
in the culture medium in the fluid chamber rise and a strong field was present in the
MCF7 cell membrane resulting a high potential at higher frequency.
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Figure 6.19: Measured voltage across Flex-MEA micro-scale electrodes on MCF7 cell spheroids
over five different frequencies – 10 kHz, 30 kHz, 50 kHz, and 70 kHz
The following part of the measurement was introducing three different concentra-
tions 10%, 50%, and 100% of dimethyl sulfoxide (DMSO), a solvent with anti-cancer
properties which target the cancer cells [156]. The measurement was performed at 10
kHz. Despite the poor connection in the experimental set-up, that was causing the low
measured voltage, figure 6.20 shows a low concentration of DMSO i.e. 10% resulted
in higher measured voltage (higher resistivity) and relatively similar as the reference
(MCF7 cell spheroid without DMSO). High DMSO concentration resulted in lower
measured voltage (low resistivity) which also means introducing concentrated DMSO
to the cell spheroid encourages cell death.
CHAPTER 6. MICRO-BIOIMPEDANCE TOMOGRAPHY MEASUREMENTS
AND ANALYSIS 112
Figure 6.20: Measured voltage across PCB micro-scale electrodes on MCF7 cell spheroids with
different DMSO concentrations; 10%, 50%, and 100%. The measurement was performed at 10
kHz
Cell death happens in the centre of the spheroid, the quiescent zone. Since the
multi-frequency EIT measurements demonstrate the changes in the cell spheroid, the
technique is potentially good and worthwhile to be applied in cell monitoring.
6.3 Micro-bioimpedance tomography on 3D microbial cul-
tures (Rhodococcus erythropolis) using Flex-MEA
The Flex-MEA was used to perform the imaging technique for real-time monitoring of
bacterial cells. The imaging of bacterial cells can be time-consuming and costly where
the conventional methods (fluorescence microscopy, electron microscopy and atomic
force microscopy) have bulky equipment.
The food industry is dependent on clean water and soil. The contamination of food
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and grain poses a severe economic and health problem for citizens throughout the world.
R. erythropolis, a type of bacteria which inhabits the soil can be hazardous to both the
farm animals and people who eat them. R. erythropolis were treated as an exemplar
biological system to investigate the application of EIT on microbial cultures using the
Flex-MEA to prove the Flex-MEA technology can be implemented on microbial cultures.
R. erythropolis were cultured in Lysogeny Broth (LB) used for bacteria growth, in
a 250 ml Erlenmeyer flask. The cells were harvested after 72 hours of growth at 30◦C
in an innova42 incubator shaker. The incubator agitates the flask, making the nutrients
in broth culture homogeneous for bacteria growth.
There are four phases in bacteria growth which are lag, exponential (log), station-
ary, and death [157]. The lag phase is the start where bacterial cells are metabolically
active but not growing. The exponential or log phase is the time where exponential
growth of the bacterial cells happens. When the bacterial cells reach a plateu, where
the number of dying cells are the same as the number of dividing cells, the bacterial cells
are known to be in the stationary phase. The cells are in the death phase when there is
an exponential decrease in the number of living bacterial cells. The phases involved in
the bacterial cells growth is shown in figure 6.21.
Figure 6.21: The four phases involved in bacteria growth [11]
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The cells were left for three days allowing cell immobilisation to be performed when
the cells were in the exponential phase. Typically, bacterial cells can be cultured in about
one day, but R. erythropolis has a slow growth rate and they reached the exponential
phase after 3 days. Figures 6.22 and 6.23 were taken from the Biolab at The University
of Edinburgh on day 0 and day 3 respectively, of the microbial culture.
Figure 6.22: R. erythropolis culture on day 0 where in the inset is a colony of R. erythropolis
Figure 6.23: R. erythropolis culture on day 3
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6.3.1 R. erythropolis cell immobilisation
LB broth culture and 3% concentration of agarose (LB3A) was prepared and the cells
entrapped within LB3A. The cell concentrations were varied for the EIT measurement,
and unfilled LB3A gel acts as the control sample. Bacterial cells are known to have a
higher growth rate at higher temperatures. The optimum growth rate for R. erythropolis
is 37◦C [158]. Hence, a group of samples were kept in an incubator, and another group
of samples were left in the refrigerator which had allowed the study and observation of
any significant difference in the EIT measurements. The cells in the incubator are in
the “normal” conditions while in the refrigerator they will grow at a slower rate or not
at all.
6.3.2 EIT measurement on R. erythropolis
Figure 6.24 illustrates the experimental set-up of EIT measurement on R. erythropolis.
Figure 6.24: The experimental set-up for EIT measurement on R. erythropolis
With the Flex-MEA, LB broth culture was first measured as the reference data.
Since the fluid chamber was downsized to a 96-well spheroid microplate, it resulted in a
slight distortion in conductivity which was, most probably, caused by the fluid meniscus
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in the chamber. The measurement was performed at room temperature on the bacterial
cells. For bacterial cells that are left in the refrigerator and believed to have a low growth
rate, a higher concentration of R. erythropolis gave much lower resistivity based on the
resistivity colour scale as can be seen in figure 6.25.
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Control
5 µl R. erythropolis
10 µl R. erythropolis
15 µl R. erythropolis
Figure 6.25: Location of R. erythropolis in the set-up and reconstructed images at 3◦C
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These results are similar to samples that were kept in the incubator at 30◦C. Higher
concentration of R. erythropolis gave much lower resistivity as shown in figure 6.26 based
on the conductivity distribution of the reconstructed images.
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Control
5 µl R. erythropolis
10 µl R. erythropolis
15 µl R. erythropolis
Figure 6.26: Location of R. erythropolis in the set-up and reconstructed images at 30◦C
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Successful detection of R. erythropolis has excellent potential not only in the
oil industry but also in the pharmaceutical field, particularly in research on vaccine
technology to prevent R. erythropolis infection in humans.
6.4 Summary
EIT measurements were performed on MCF7 spheroids with cell concentration: 2.4 ×
105 cells ml−1 and spheroid size: 0.71 mm. Since the fluid chamber is small, the liquid
level is not flat, and when the MCF7 spheroid was released into the sensor, fresh culture
medium will also be added, hence changing the liquid volume as well as the liquid level.
These may cause severe image deformation especially when the cell spheroid is too small.
The image reconstruction algorithm used in the experiment is Tikhonov regulari-
sation [119] as this method produced less unwanted errors as presentedn in 6.2.2. When
moving from larger electrodes (on PCB) to micro-scale electrodes (Flex-MEA), it is
challenging to achieve high-resolution images in image reconstruction. However, this
work has proven that the EIT system is capable of reconstructing the images of MCF7
spheroids placed on the micro-scale electrodes through electrical conductivity distribu-
tion.
There are challenges in EIT to reconstruct MCF7 spheroid images from a large
scale to smaller scale. In improving the reconstructed images, a more efficient iterative
algorithm will be implemented. Future work is to monitor the drug effect on MCF7
spheroids in real-time via EIT imaging.
From the results attained by incorporating Flex-MEA with EIT on microbial
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cultures, we are able to say that EIT is the best fit as a portable, non-invasive
technique to image the growth of microbial cultures, R. erythropolis. Unfilled and filled
LB3A gels are more conductive than LB broth culture. Successful measurement of





Micro-bioimpedance tomography of micro-scale 3D cell cultures and its application in
the disease model to replace the use of animal in an experiment is under-explored in the
research literature review in chapters 2 and 3. Hence, this research proposed a technique
that can be implemented in drug development and eliminating animal testing.
Prior to designing and producing the electrodes for micro-bioimpedance tomogra-
phy, FEM was performed to evaluate the optimum electrode layout and results presented
in chapter 4. A series of EIT devices were designed and presented in chapter 5, from
millimetre-scale to micrometre-scale electrode arrays, to determine an optimal electrode
arrangement for micro-bioimpedance tomography. Several approaches had been inves-
tigated to incorporate the multielectrode arrays with micro-bioimpedance tomography,
including, i) varying the morphology of the electrode arrays, ii) comparing the regular-
isation methods for image reconstruction, and iii) measurements of cell spheroids and
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3D microbial structures. The micro-scale electrode arrays were designed with biocom-
patible outward-facing materials to avoid any physiological changes to the micro-scale
cell and microbial cultures during measurements.
The first micro-scale electrodes were fabricated on a PCB (millimetre-scale) and
they were NiAu electrodes. The second electrode design was scaled down to micro-
scale electrodes to accommodate the micro-bioimpedance tomography of micro-scale
3D cell cultures. These electrodes were manufactured on a glass substrate. The first two
designs are representing the planar electrodes. The final micro-scale electrodes design,
Flex-MEA, was fabricated on a flexible PCB and represent 3D electrodes.
In a time-dependent analysis, the frequency was set at 10 kHz, 1.5 mA sinusoidal
currents applied on two adjacent electrodes with 180◦ phase difference, at which the
cells would respond steadily. When current was sourced through a pair of electrodes,
an electric field was distributed with a well of a culture plate. The reconstructed EIT
images mapped the variation in conductivity in a sample within the well.
Another factor faced by this research was to produce high-resolution images since
the quality of image reconstruction of micro-scale cell, and microbial cultures are
weak. In order to solve this situation, the regularisation methods involving Tikhonov,
Gaussian-Laplace and L1 for image reconstruction in micro-scale EIT for biomedical
applications had been studied.
For test samples with higher conductivity, the Gaussian-Laplace regularisation
was found to give the closest representation of the experimental set-up. However, the
intensity derived by Gaussian-Laplace regulation was not as high as L1 regularisation.
Tests, with samples of higher conductivity, were carried out using the L1 regularisation.
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The reconstructed image was found to be more stable. However, errors were still visible.
Similarly, for test samples with a lower conductivity, the closest image reconstruction
was achieved by Gaussian-Laplace regularisation, despite having a lower intensity as
compared to L1 regularisation. Again, errors were still visible.
These two regularisation methods were seen to produce strong reconstructed
images, despite the presence of some errors. However, Tikhonov regularisation seemed
to provide the least errors among the three state-of-the-art regularisation methods.
Therefore, Tikhonov regularisation was selected as the preferred regularisation method
for image reconstruction in this research work. Perturbing issues aroused in this
regularisation method, in relation to bio-impedance tomography, were resolved by
refining the optimisation algorithm.
Achieving high-resolution images in image reconstruction was found to be very
challenging in this study, in particular, when scaling down the arrays from larger
electrodes to micro-scale electrodes. Firstly, the image deformation might be caused by
culture medium addition when MCF7 spheroid was released into the 6.4 mm diameter
chamber, as presented in chapter 6. Secondly, the electrode sensing area was minimal,
resulting in a lower voltage differential. Lower voltage differential was possibly due to
the lower resistance (R) associated with micro-scale electrodes. However, the interfacial
resistance may be larger if it is dependent on surface area which would affect the
sensitivity. These are the possible causes that might affect image deformation and
prevent in achieving high-resolution images.
The above situation was overcome by a new micro-scale electrode design. It is the
PCB fabricated on a flexible PCB with improved electrode arrangement compared with
planar electrodes made on a glass substrate. When the PCB electrodes are positioned
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on the chamber wall, an electric field is found to be evenly distributed within the 3D
cell structure in the chamber, resulting in improved sensitivity. Multiple laboratory
tests had been carried out on MCF7 spheroids and 3D R. erythropolis cultures. From
the results obtained, the PCB showed more stable voltage measurements and produced
high-resolution images compared with the fabricated planar electrodes.
A Flex-MEA technology with improved image reconstruction technique on micro-
scale 3D cell cultures was developed. This technology gave high-throughput analysis in
basic research of drug discovery allowing researchers to conduct a large number of tests
in a short period of time and introducing a time-efficient process in finding new drugs.
7.2 Outlook
The research has proven that the final design of PCB, fabricated on a flexible PCB with
improved micro-scale electrode geometry arrangement, was found to be very versatile
in analysing cancer cells with high-resolution imaging which can be applied both in
vitro or in vivo. When it is designed and structured with advanced multi-electrode
geometric configuration, PCB will have a greater potential for a much wider application.
Almost all types of organ cells, stem cells or other specimens, such as tumour cells,
drugs, that are electrogenic, can be analysed and characterised readily in vitro. The
achievement of the work has further illustrated the continuing trend of merging medical
and pharmaceutical disciplines with engineering technology. There are other possible
opportunities in applying the PCB, such as, understanding cell degeneration, biology
of cancer cells, and identifying the effectiveness of anti-cancer drug in treating cancer.
CHAPTER 7. CONCLUSIONS AND OUTLOOK 126
Other future possibility of PCB application is drug-monitoring as in the pharmaceutical
technology application.
By incorporating Flex-MEAs with EIT, we can introduce a new technique com-
prising organ-on-chip technology, tomographic imaging technique and optimising image
reconstruction using machine learning, that would help to reduce the cost of drug de-
velopment. In expanding the research on a broader scope, it would help to develop new
drugs, cancer or disease treatment, vaccines, and save millions of animals from being
killed in experimental laboratories for improving the quality of life.
Finally, improving systems in the laboratory and incorporating them into real-world
applications is the ultimate driving force for electronics and biomedical advances. Inte-
grating these complementary fields will help to surpass the limitations and dramatically
expands the freedom of designing medical devices, extending further to a larger area
of applications involving environmental monitoring and corrosion monitoring in oil and
gas industry apart from medical applications.
List of publications
Y. Yang, J. Jia, S. Smith, N. Jamil, W. Gamal & P.O. Bagnaninchi, “A Miniature
Electrical Impedance Tomography Sensor and 3-D Image Reconstruction for Cell
Imaging”, IEEE Sensors Journal, vol. 17, no. 2, pp. 514-523, 2017.
N. Jamil, Y. Yang, M. Cela, L.P. Basanta, E.O. Blair, S. Dimartino, J. Jia & S. Smith,
“Flexible microelectrode array (Flex-MEA) design for micro-bioimpedance tomography
of microbial cultures”, 4th Conference on Impedance-Based Cellular Assays, Edinburgh,
Scotland, June 2018.
N. Jamil, Y. Yang, A. Tsiamis, J. Jiabin, & S. Smith, “Comparison of Regularisa-
tion Methods in Image Reconstruction for Micro-Bioimpedance Tomography”, IEEE
Sensors, Glasgow, Scotland, October 2017.
N. Jamil, Y. Yang, A. Tsiamis, J. Jiabin, & S. Smith, “Design and fabrication of
different platinum microelectrodes morphologies for electrical impedance tomography
in biomedical applications”, 5th International Conference on Bio-Sensing Technology,
Riva del Garda, Italy, May 2017.
N. Jamil, S. Smith, Y. Yang, J. Jia, P.O. Bagnaninchi & E. González-Fernández,
“Design and fabrication of microelectrodes for electrical impedance tomography of cell
spheroids”, IEEE EMBS Conference on Biomedical Engineering and Sciences, pp. 426-
431, Kuala Lumpur, Malaysia, December 2016.
N. Jamil, Y. Yang, J. Jia, A.F. Murray, & S. Smith, “Fabrication of gold-plated
electrodes on a printed circuit board (PCB) for electrical impedance tomography (EIT)
measurement in fluid environment”, MicroTech 2016 - Sensors, MEMS & Advanced
Packaging, Edinburgh, Scotland, March 2016.
LIST OF PUBLICATIONS 128
A. Buchoux,N. Jamil, A. Tsiamis & S. Smith, “Packaging of Silicon Chip by Selectively
Curing a Photosensitive Acrylic Resin with a DLP Projector”,MicroTech 2016 - Sensors,
MEMS & Advanced Packaging, Edinburgh, Scotland, March 2016.
A. Tsiamis, Y. Li, N. Jamil, S. Smith, H.M. Reekie, J. Terry, A.J. Walton & A.F.
Murray, “On-Chip Post-Processing Fabrication Techniques for Extended Gate ISFET
pH Sensors”, 4th International Conference on Bio-Sensing Technology, Lisbon, Portugal,
May 2015.
Bibliography
[1] “What Is a Cell?.” https://www.yourgenome.org/facts/what-is-a-cell. Accessed:
2018-5-11.
[2] G. Cooper, The Cell: A Molecular Approach. Sunderland (MA): Sinauer Asso-
ciates, 2000.
[3] PHRMA, “Biopharmaceutical Research & Development : The Process Behind
New Medicines,” 2015.
[4] “T25 Flask Sigma Aldrich.” http://www.sigmaaldrich.com. Accessed: 2016-12-18.
[5] “Electrical impedance tomography.” http://psychology.wikia.com/wiki/
Electrical_impedance_tomography. Accessed: 2015-09-18.
[6] “Electrical impedance tomography.” https://en.wikipedia.org/wiki/Electrical_
impedance_tomography#cite_note-Holder-8. Accessed: 2018-1-1.
[7] A. Adler and A. Boyle, “Electrical Impedance Tomography : Tissue Properties to
Image Measures.”
[8] A. S. Pandya, A. Arimoto, A. Agarwal & Y. Kinouchi, “A Novel Approach for
Measuring Electrical Impedance Tomography for Local Tissue with Artificial
Intelligent Algorithm,” International Journal of Biometrics and Bioinformatics,
vol. 3, no. 5, pp. 66–81, 2009.
[9] A. J McKane, T. Biancalani, and T. Rogers, “Stochastic pattern formation and
spontaneous polarisation: The linear noise approximation and beyond,” Bulletin
of mathematical biology, vol. 76, 03 2013.
BIBLIOGRAPHY 130
[10] Y. Mamatjan, D. Gürsoy, and A. Adler, “Electrode positions and current patterns
for 3D EIT,” 12th International Conference in Electrical Impedance Tomography,
2011.
[11] “Growth of bacterial populations.” https://www.britannica.com/science/
bacteria/Growth-of-bacterial-populations. Accessed: 2018-7-11.
[12] J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. M.
Parkin, D. Forman, and F. Bray, “Cancer incidence and mortality worldwide:
Sources, methods and major patterns in GLOBOCAN 2012,” International Jour-
nal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015.
[13] C. K. Anders and L. a. Carey, “Biology, Metastatic Patterns and Treatment of
Patients with Triple-Negative Breast Cancer,” Breast, vol. 9, no. Suppl 2, pp. S73–
S81, 2010.
[14] M. Arora, “Cell Culture Media: A Review,” Mater Methods, no. 3, p. 175, 2013.
[15] “Studying Cells.” https://courses.lumenlearning.com/boundless-biology/chapter/
studying-cells/. Accessed: 2015-09-18.
[16] “Cell Biology.” https://www.nature.com/scitable/topic/cell-biology-13906536.
Accessed: 2017-09-18.
[17] C. Boshoff, “Understanding cancer,” Nature, vol. 444, no. 7119, pp. 549–549, 2006.
[18] “What is a cell?.” https://ghr.nlm.nih.gov/primer/basics/cell. Accessed: 2018-5-
11.
[19] “What Is a Cell?.” https://www.nature.com/scitable/topicpage/
what-is-a-cell-14023083. Accessed: 2018-5-11.
[20] W. Liu, Y. Deng, Y. Liu, W. Gong, and W. Deng, “Stem cell models for
drug discovery and toxicology studies,” Journal of Biochemical and Molecular
Toxicology, vol. 27, no. 1, pp. 17–27, 2013.
[21] A.-A. D. Lakraj, B. Jabbari, and D. G. Machado, “Chapter 25 - neuronal networks
and therapeutics in neurodegenerative disorders,” in Neuronal Networks in Brain
Function, CNS Disorders, and Therapeutics (C. L. Faingold and H. Blumenfeld,
eds.), pp. 335 – 348, San Diego: Academic Press, 2014.
BIBLIOGRAPHY 131
[22] A. N. Orekhov and E. A. Ivanova, “Chapter 5 - antiatherosclerotic efficacy
of nutraceuticals,” in Nutraceuticals (R. C. Gupta, ed.), pp. 61 – 73, Boston:
Academic Press, 2016.
[23] S. Srivastava, S. Mishra, J. Dewangan, A. Divakar, P. K. Pandey, and S. K. Rath,
“Chapter 2 - principles for in vitro toxicology,” in In Vitro Toxicology (A. Dhawan
and S. Kwon, eds.), pp. 21 – 43, Academic Press, 2018.
[24] J. Hardy, “Julius Petri and his Petri Plate Invention - History of the Petri Dish,”
1880.
[25] S. R. Caliari and J. A. Burdick, “A practical guide to hydrogels for cell culture,”
Nature Methods, vol. 13, no. 5, pp. 405–414, 2016.
[26] A. Abbott, “Biology’s new dimension,” Nature, vol. 424, no. August, pp. 870–872,
2003.
[27] B. L. Duell, A. W. Cripps, M. A. Schembri, and G. C. Ulett, “Epithelial
cell coculture models for studying infectious diseases: Benefits and limitations,”
Journal of Biomedicine and Biotechnology, vol. 2011, 2011.
[28] M. Bhattacharya, M. M. Malinen, P. Lauren, Y. R. Lou, S. W. Kuisma, L. Kanni-
nen, M. Lille, A. Corlu, C. Guguen-Guillouzo, O. Ikkala, A. Laukkanen, A. Urtti,
and M. Yliperttula, “Nanofibrillar cellulose hydrogel promotes three-dimensional
liver cell culture,” Journal of Controlled Release, vol. 164, no. 3, pp. 291–298,
2012.
[29] G. R. Souza, J. R. Molina, R. M. Raphael, M. G. Ozawa, D. J. Stark, C. S.
Levin, L. F. Bronk, J. S. Ananta, J. Mandelin, M.-M. Georgescu, J. A. Bankson,
J. G. Gelovani, T. C. Killian, W. Arap, and R. Pasqualini, “Three-dimensional
tissue culture based on magnetic cell levitation,” Nat Nanotechnol., vol. 5, no. 4,
pp. 291–296, 2010.
[30] A. Y. Hsiaoa, Y.-C. Tung, X. Qu, L. R. Patel, K. J. Pienta, and S. Takayama,
“384 Hanging drop arrays give excellent Z-factors and allow versatile formation of
co-culture spheroids,” Biotechnol Bioeng., vol. 109, no. 5, pp. 1293–1304, 2012.
[31] E. M. Ahmed, “Hydrogel: Preparation, characterization, and applications: A
review,” Journal of Advanced Research, vol. 6, no. 2, pp. 105 – 121, 2015.
BIBLIOGRAPHY 132
[32] B. L. Roach, A. B. Nover, G. A. Ateshian, and C. T. Hung, Agarose Hydrogel
Characterization for Regenerative Medicine Applications: Focus on Engineering
Cartilage, ch. 16, pp. 258–273. John Wiley & Sons, Ltd, 2016.
[33] W. L. Haisler, D. M. Timm, J. A. Gage, H. Tseng, T. C. Killian, and G. R. Souza,
“Three-dimensional cell culturing by magnetic levitation,” Nature Protocols, vol. 8,
no. 10, pp. 1940–1949, 2013.
[34] J. A. Zimmermann and T. C. Mcdevitt, “Pre-conditioning mesenchymal stromal
cell spheroids for immunomodulatory paracrine factor secretion,” Cytotherapy,
vol. 16, no. 3, pp. 331–345, 2014.
[35] “Cell division and cancer.” https://www.nature.com/scitable/topicpage/
cell-division-and-cancer-14046590. Accessed: 2018-5-11.
[36] “What Is Cancer?.” https://www.cancer.org/cancer/cancer-basics/
what-is-cancer.html. Accessed: 2017-11-14.
[37] “Disease model.” http://www.nature.com/subjects/disease-model. Accessed:
2017-06-01.
[38] J. L. Sterneckert, P. Reinhardt, and H. R. Schöler, “Investigating human disease
using stem cell models,” Nature Reviews Genetics, vol. 15, no. 9, pp. 625–639,
2014.
[39] M. J. Prescott, “The Three Rs,” The International Encyclopedia of Primatology,
pp. 1–5, 2017.
[40] M. L. Graham and M. J. Prescott, “The multifactorial role of the 3Rs in shifting
the harm-benefit analysis in animal models of disease,” European Journal of
Pharmacology, vol. 759, pp. 19–29, 2015.
[41] “The 3Rs.” https://www.nc3rs.org.uk/the-3rs#The\%203Rs\%20definitions. Ac-
cessed: 2019-5-1.
[42] “Drug discovery and development.” https://www.nature.com/subjects/
drug-discovery-and-development. Accessed: 2017-09-18.
[43] Pharmaceutical Research and Manufacturers of America, “Drug Discovery and
Development, Drug Discovery,” tech. rep., Pharmaceutical Research and Manu-
facturers of America, 2006.
BIBLIOGRAPHY 133
[44] D. L. Holliday and V. Speirs, “Choosing the right cell line for breast cancer
research,” Breast Cancer Research, vol. 13, no. 215, pp. 1–7, 2011.
[45] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, “Molecular
Biology of the Cell. 4th edition,” 2002.
[46] H. Page, P. Flood, and E. G. Reynaud, “Three-dimensional tissue cultures:
Current trends and beyond,” Cell and Tissue Research, vol. 352, no. 1, pp. 123–
131, 2013.
[47] S. A. Langhans, “Three-dimensional in vitro cell culture models in drug discovery
and drug repositioning,” Frontiers in Pharmacology, vol. 9, p. 6, 2018.
[48] T.-m. Achilli, J. Meyer, and J. R. Morgan, “Advances in the formation, use and
understanding of multi- cellular spheroids,” Expert Opin Biol Ther, vol. 12, no. 10,
pp. 1347–1360, 2012.
[49] D. Rogozhnikov, P. J. O’Brien, S. Elahipanah, and M. N. Yousaf, “Scaffold
Free Bio-orthogonal Assembly of 3-Dimensional Cardiac Tissue via Cell Surface
Engineering,” Scientific Reports, vol. 6, no. 1, p. 39806, 2016.
[50] M. Bissell, “Mina Bissell,” Nature Medicine, vol. 11, no. 3, p. 242, 2005.
[51] “Spheroids And 3d Cell Culture: A Brief History.” https://www.thermofisher.
com/blog/cellculture/a-brief-history-of-spheroids-and-3. Accessed: 2018-01-29.
[52] C. Neeley, “A Brief History of Spheroids,” 2016.
[53] C. Neeley, “The use of spheroids in cancer research,” 2015.
[54] R. Allison, “Spheroid Cultures for Cancer Research and Treatment,” 1990.
[55] “Catabolism.” http://goldbook.iupac.org/html/C/C00870.html. Accessed: 2018-
5-11.
[56] S. Bhat and A. Kumar, “Biomaterials and bioengineering tomorrow’s healthcare,”
Biomatter, vol. 3, no. 3, 2013.
[57] C. Grüber and R. A. Wood, Role of Vaccines. Elsevier Inc., 2015.
[58] Kutzler Michele A. and D. B. Weiner, “DNA vaccines: ready for prime time?,”
Nat Rev Genet. 2008, vol. 9, no. 10, pp. 776–788, 2008.
BIBLIOGRAPHY 134
[59] W. W. Leitner, H. Ying, and N. P. Restifo, “DNA and RNA-based vaccines:
principles, progress and prospects,” Vaccine, vol. 18, no. 9-10, pp. 765–777, 1999.
[60] “How vaccines are tested, licensed and monitored.” http://vk.ovg.ox.ac.uk/
vaccine-development. Accessed: 2018-5-11.
[61] J. Melorose, R. Perroy, and S. Careas, “Study Guide - Biotechnology and Cell
Culture,” Study Guide - Biotechnology and Cell Culture, vol. 1, p. 2604, 2015.
[62] M. C. Phelan, “Basic techniques in mammalian cell tissue culture,” Curr Protoc
Cell Biol, vol. Chapter 1, p. Unit 1 1, 2007.
[63] “Cell Types & Culture Characteristics.” https://www.sigmaaldrich.com/
technical-documents/protocols/biology/cell-types-culture.html. Accessed: 2018-
5-11.
[64] Cellgro, “Dissociation of Cell Monolayers Using Trypsin Solutions,” Corning
Incorporated Press, p. 1, 2012.
[65] J. V. May and D. W. Schomberg, “The effect of plating density on granulosa cell
growth and differentiation in vitro.,” Molecular and cellular endocrinology, vol. 34,
no. 3, pp. 201–213, 1984.
[66] C. D. Donaldson and K. N. Bishop, “Cell culture,” British Journal Of Hospital
Medicine (London, England: 2005, vol. 76, no. 1, 2015.
[67] V. Gupta, M. Sengupta, J. Prakash, and B.-C. Tripathy, Basic and Applied Aspects
of Biotechnology. Springer International Publishing, 2017.
[68] F. A. Khan, Biotechnology Fundamentals. CRC Press LLC, 2017.
[69] A. K.-L. Chen, S. Reuveny, and S. K. W. Oh, “Application of human mesenchymal
and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements
and future direction,” Biotechnology Advances, vol. 31, no. 7, pp. 1032–1046, 2013.
[70] Y. Fang and R. M. Eglen, “Three-Dimensional Cell Cultures in Drug Dis-
covery and Development,” SLAS DISCOVERY: Advancing Life Sciences R&D,
p. 247255521769679, 2017.
[71] S. Sanyal, “Culture and Assay Systems Used for 3D Cell Culture,” Corning, 2014.
[72] B. M. P. H. P. Puttaraju and B. C. K. Murthy,Molecular biology and biochemistry:
A lab manual. New India Publishing Agency, 2008.
BIBLIOGRAPHY 135
[73] Z. Bartlett, “The Hayflick Limit,” 2014.
[74] Invitrogen, “Cell Culture Basics Handbook,” ThermoFisher Scientific Inc., pp. 1–
61, 2010.
[75] T. Yao and Y. Asayama, “Animal-cell culture media: History, characteristics, and
current issues,” Reproductive Medicine and Biology, vol. 16, no. 2, pp. 99–117,
2017.
[76] PAA, “PA Serum Brochure,” 2013.
[77] S. L. Gersen and M. B. Keangle, eds., The principles of clinical cytogenetics.
Humana Press, 2005.
[78] S. S. Ronald Pethig, ed., Introductory Bioelectronics: For Engineers and Physical
Scientists. John Wiley and Sons Ltd, 2013.
[79] C. Roth, “Cell Passage and Use of Trypsin,” 2009.
[80] N. S. Templeton, ed., Gene and cell therapy: Therapeutic mechanisms and strate-
gies. Marcel Dekker, Inc, 2005.
[81] X. Bao and S. Palecek, Chapter 1 – Genetic Engineering in Stem Cell Biomanu-
facturing. Elsevier B.V., 2016.
[82] I. A. Cree, ed., Cancer Cell Culture - Methods and Protocols. Springer Sci-
ence+Business Media, second ed., 2011.
[83] C. K. N., Basic concept of biotechnology. Laxmi Book Publication, 2015.
[84] Gibco, “Cell culture basics Now includes transfection,” 2014.
[85] R. I. Freshney, Culture of Animal Cells: A Manual of Basic Technique. Wiley-Liss,
New York, 1994.
[86] C. Skourou, P. J. Hoopes, R. R. Strawbridge, and K. D. Paulsen, “Feasibility
studies of electrical impedance spectroscopy for early tumor detection in rats,”
Physiological Measurement, vol. 25, no. 1, p. 335, 2004.
[87] H. P. Schwan, “The practical success of impedance techniques from an historical
perspective,” 1999.
[88] D. A. Borkholder, Cell Based Biosensors Using Microelectrodes. PhD thesis,
Stanford University, 1998.
BIBLIOGRAPHY 136
[89] W. J.G., Electrical Impedance Tomography. Adam Hilger, Bristol, 1990.
[90] A. F. Kanta and A. Decroly, “Stainless steel electrode characterizations by elec-
trochemical impedance spectroscopy for dye-sensitized solar cells,” Electrochimica
Acta, vol. 56, no. 27, pp. 10276–10282, 2011.
[91] G. Voskerician, M. S. Shive, R. S. Shawgo, H. von Recum, J. M. Anderson, M. J.
Cima, and R. Langer, “Biocompatibility and biofouling of mems drug delivery
devices,” Biomaterials, vol. 24, no. 11, pp. 1959 – 1967, 2003.
[92] C. Canali, A. Heiskanen, H. B. Muhammad, P. Høyum, F.-J. Pettersen, M. Hem-
mingsen, A. Wolff, M. Dufva, Ørjan Grøttem Martinsen, and J. Emnéus,
“Bioimpedance monitoring of 3d cell culturing—complementary electrode config-
urations for enhanced spatial sensitivity,” Biosensors and Bioelectronics, vol. 63,
pp. 72 – 79, 2015.
[93] H. Yin, F. L. Wang*, A. L. Wang, J. Cheng, and P. Y. Zhou, “Bioelectrical
impedance assay to monitor changes in aspirin-treated human colon cancer ht-
29 cell shape during apoptosis,” Analytical Letters, vol. 40, no. 1, pp. 85–94, 2007.
[94] P. J. Yang, V. V. Halbach, R. T. Higashida, and G. B. Hieshima, “Platinum wire:
a new transvascular embolic agent.,” American Journal of Neuroradiology, vol. 9,
no. 3, pp. 547–550, 1988.
[95] C.-Y. Chen, E. Tamiya, K. Ishihara, Y. Kosugi, Y.-C. Su, N. Nakabayashi,
and I. Karube, “A biocompatible needle-type glucose sensor based on platinum-
electroplated carbon electrode,” Applied Biochemistry and Biotechnology, vol. 36,
p. 211, Sep 1992.
[96] A. R. Kherlopian, T. Song, Q. Duan, M. A. Neimark, M. J. Po, J. K. Gohagan,
and A. F. Laine, “A review of imaging techniques for systems biology.,” BMC
systems biology, vol. 2, p. 74, 2008.
[97] M. Weyland and P. a. Midgley, “Extending energy-filtered transmission electron
microscopy (EFTEM) into three dimensions using electron tomography.,” Micros.
Microanal., vol. 9, pp. 542–555, 2003.
[98] F. Bistolfi, “Alessandro Vallebona,” Fisica in Medicina, vol. 2, pp. 115 – 123, 2005.
[99] B. Pollak, “Experiences with Planography,” Diseases of the Chest, vol. 24, no. 6,
pp. 663–669, 1953.
BIBLIOGRAPHY 137
[100] J. T. Littleton and M. L. Durizsch Littleton, “Conventional Tomography,” 1996.
[101] “The Nobel Prize in Physiology or Medicine 1979.” https://www.nobelprize.org/
nobel_prizes/medicine/laureates/1979/. Accessed: 2017-06-30.
[102] R. Bayford, I. Roitt, T. Rademacher, A. Demosthenous, and R. Iles, “Detection of
cancer with electrical impedance tomography,” Sept. 8 2015. US Patent 9,125,583.
[103] S. N. Prasad, D. Houserkova, and J. Campbell, “Breast imaging using 3D
electrical impedence tomography.,” Biomedical papers of the Medical Faculty of
the University Palack??, Olomouc, Czechoslovakia, vol. 152, no. 1, pp. 151–154,
2008.
[104] V. Cherepenin, A. Karpov, A. Korjenevsky, V. Kornienko, A. Mazaletskaya,
D. Mazourov, and D. Meister, “A 3d electrical impedance tomography (eit) system
for breast cancer detection,” Physiological Measurement, vol. 22, no. 1, p. 9, 2001.
[105] Y. Yang, J. Jia, S. Smith, S. Member, N. Jamil, W. Gamal, and P. Bagnaninchi, “A
Miniature Electrical Impedance Tomography Sensor and 3D Image Reconstruction
for Cell Imaging,” IEEE Sensors Journal, vol. 17, no. 2, pp. 514–523, 2017.
[106] T. Sun, S. Tsuda, K.-P. Zauner, and H. Morgan, “On-chip electrical impedance
tomography for imaging biological cells,” Biosensors & Bioelectronics, vol. 25,
no. 5, pp. 1109–1115, 2010.
[107] V. Cherepenin, A. Karpov, A. Korjenevsky, and V. Kornienko, “A 3D electrical
impedance tomography ( EIT ) system,” Physiological Measurement, vol. 22,
pp. 9–18, 2001.
[108] A. P. Bagshaw, A. D. Liston, R. H. Bayford, A. Tizzard, A. P. Gibson, A. T.
Tidswell, M. K. Sparkes, H. Dehghani, C. D. Binnie, and D. S. Holder, “Electrical
impedance tomography of human brain function using reconstruction algorithms
based on the finite element method,” NeuroImage, vol. 20, no. 2, pp. 752–764,
2003.
[109] N. Kerrouche, C. McLeod, and W. Lionheart, “Time series of EIT chest images
using singular value decomposition and Fourier transform,” Physiol. Meas., vol. 22,
no. 1, pp. 147–157, 2001.
[110] M. Soleimani, C. Gómez-Laberge, and A. Adler, “Imaging of conductivity changes
and electrode movement in EIT,” Physiological Measurement, vol. 27, no. 5, 2006.
BIBLIOGRAPHY 138
[111] B. H. Brown and A. D. Seagar, “The Sheffield data collection system,” Clinical
Physics and Physiological Measurement, 1987.
[112] P. Hua, J. G. Webster, and W. J. Tompkins, “A regularised electrical impedance
tomography reconstruction algorithm,” Clinical Physics and Physiological Mea-
surement, pp. 0–5, 1988.
[113] B. Buntz, “Biomaterials and the Future of Medical Devices.” https://www.
mddionline.com/biomaterials-and-future-medical-devices. Accessed: 2017-06-30.
[114] C. Fillers, “Conductive Plastic / Polymer Additives Conductive Plastic / Polymer
Additives.”
[115] M. L. Huffman and B. J. Venton, “Carbon-Fiber Microelectrodes for In Vivo
Applications,” Analyst, vol. 134, no. 1, pp. 18–24, 2010.
[116] D. D. Zhou, X. T. Cui, A. Hines, and R. J. Greenberg, Conducting polymers in
neural stimulation applications. Springer Science+Business Media, 2010.
[117] P. Metherall, D. C. Barber, R. H. Smallwood, and B. H. Brown, “Three-
dimensional electrical impedance tomography,” Nature, vol. 380, pp. 509–512,
1996.
[118] N. Polydorides and W. R. B. Lionheart, “A Matlab toolkit for three-dimensional
electrical impedance tomography: a contribution to the Electrical Impedance
and Diffuse Optical Reconstruction Software project,” Measurement Science and
Technology, vol. 13, no. 12, pp. 1871–1883, 2002.
[119] M. Vauhkonen, D. Vadász, P. A. Karjalainen, E. Somersalo, and J. P. Kaipio,
“Tikhonov regularization and prior information in electrical impedance tomogra-
phy.,” IEEE transactions on medical imaging, vol. 17, no. 2, pp. 285–93, 1998.
[120] B. M. Graham and A. Adler, “Electrode placement configurations for 3D EIT,”
Physiological measurement, vol. 28, no. 7, pp. S29–S44, 2007.
[121] Q. Wang and Wang H, “Image Reconstruction Based on L1 Regularization for
Electrical Impedance Tomography (EIT),” Instrumentation and Measurement
Technology Conference (I2MTC), 2011 IEEE, pp. 5–9, 2011.
[122] L. Borcea, “Electrical impedance tomography,” Inverse Problems, vol. 18, no. 6,
pp. R99–R136, 2002.
BIBLIOGRAPHY 139
[123] C. J. Kotre, “A sensitivity coefficient method for the reconstruction of electrical
impedance tomograms,” Clinical Physics and Physiological Measurement, vol. 10,
no. 3, pp. 275–281, 1989.
[124] L. Zhang, “Image reconstruction algorithm for electrical impedance tomography
using updated sensitivity matrix,” Soft Computing and Pattern Recognition (SoC-
PaR), 2011 International Conference of, pp. 248–252, 2011.
[125] E. V. D. Berg and M. P. Friedlander, “Probing the Pareto Frontier for Basis
Pursuit Solutions,” Society for Industrial and Applied Mathematics, vol. 31, no. 2,
pp. 890–912, 2008.
[126] “The Finite Element Method (FEM).” https://www.comsol.com/multiphysics/
finite-element-method. Accessed: 2017-12-02.
[127] T. D. Shook and R. S. Reddy Gorla, “Finite element analysis and redesign of a
compressor hub spinner,” Finite Elements in Analysis and Design, vol. 28, no. 1,
pp. 19–31, 1997.
[128] O. de Weck and I. Y. Kim, “Finite Element Method,” Engineering Design and
Rapid Prototyping, vol. 810, p. 26, 2004.
[129] F. Rattay, S. M. Danner, U. S. Hofstoetter, and K. Minassian, Finite Element
Modeling for Extracellular Stimulation, pp. 1–12. New York, NY: Springer New
York, 2013.
[130] V. B. C. Tan, M. X. Tong, K. M. Lim, and C. T. Lim, “Finite Element Modeling
of Electronic Packages Subjected to Drop Impact,” Packaging (Boston, Mass.),
vol. 28, no. 3, pp. 555–560, 2005.
[131] “Modeling and Simulation.” https://www.mathworks.com/discovery/
modeling-and-simulation.html. Accessed: 2017-12-02.
[132] R. N. Nanhorngué, F. Pesavento, and B. A. Schrefler, “Sensitivity analysis applied
to finite element method model for coupled multiphase system,” International
Journal for Numerical and Analytical Methods in Geomechanics, vol. 37, pp. 2205–
2222, 2013.
[133] W. Becker, J. Rowson, J. Oakley, A. Yoxall, G. Manson, and K. Worden, “Bayesian
sensitivity analysis of a large nonlinear model,” 2008.
BIBLIOGRAPHY 140
[134] A. J. Bard and L. R. Faulkner, Electrochemical Methods: Fundamentals and
Applications. John Wiley and Sons Inc, Dec. 2001.
[135] R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde, and M. Sastry, “Bio-
compatibility of gold nanoparticles and their endocytotic fate inside the cellular
compartment: A microscopic overview,” Langmuir, vol. 21, no. 23, pp. 10644–
10654, 2005. PMID: 16262332.
[136] I. Rose and C. Whittington, Nickel Plating Handbook. Nickel Institute, 2014.
[137] P. A. Kohl, “Electrodeposition of Gold,” Modern Electroplating: Fifth Edition,
pp. 115–130, 2011.
[138] J. Meija, T. B. Coplen, M. Berglund, W. A. Brand, P. De Bièvre, M. Gröning,
N. E. Holden, J. Irrgeher, R. D. Loss, T. Walczyk, and T. Prohaska, “Atomic
weights of the elements 2013 (IUPAC Technical Report),” Pure and Applied
Chemistry, vol. 88, no. 3, pp. 265–291, 2016.
[139] “Potassium cyanide.” https://pubchem.ncbi.nlm.nih.gov/compound/potassium_
cyanide. Accessed: 2018-17-11.
[140] J. H. Clark and M. J. Braithwaite, Applications of Hydrogen Peroxide and
Derivatives. RSC Clean Technology Monographs, The Royal Society of Chemistry,
1999.
[141] “TARGET 3001! PCB Layout CAD.” http://ibfriedrich.com/en/index.html. Ac-
cessed: 2017-12-12.
[142] T. R. Kucklick, “Assessing Biocompatibility,” The Medical Device R&D Handbook,
Second Edition, pp. 1–27, 2013.
[143] a. Mohr, W. Finger, K. Fohr, W. Nisch, and W. Gopel, “Performance Of A
Thin Film Microelectrode Array For Monitoring Electrogenic Cells In Vitro,”
Proceedings of the International Solid-State Sensors and Actuators Conference -
TRANSDUCERS ’95, vol. 2, pp. 265–269, 1995.
[144] L. Wang, J. Zhu, C. Deng, W.-l. Xing, and J. Cheng, “An automatic and quanti-
tative on-chip cell migration assay using self-assembled monolayers combined with
real-time cellular impedance sensing,” Lab on a Chip, vol. 8, no. 6, p. 872, 2008.
BIBLIOGRAPHY 141
[145] A. R. A. Rahman, C.-M. Lo, and S. Bhansali, “A micro-electrode array biosensor
for impedance spectroscopy of human umbilical vein endothelial cells,” Sensors
and Actuators B, vol. 118, no. 1-2, pp. 115–120, 2006.
[146] M. Kuperstein and D. A. Whittington, “A Practical 24 Channel Microelectrode
for Neural Recording in Vivo,” IEEE Transactions on Biomedical Engineering,
vol. BME-28, no. 3, pp. 288–293, 1981.
[147] P. Linderholm, T. Braschler, J. Vannod, Y. Barrandon, M. Brouard, and P. Re-
naud, “Two-dimensional impedance imaging of cell migration and epithelial strat-
ification,” Lab on a Chip, vol. 6, no. 9, p. 1155, 2006.
[148] W. Gamal, Real-time bioimpedance measurements of stem cell-based disease
models-on-a-chip. PhD thesis, The University of Edinburgh, 2015.
[149] N. F. Sheppard, R. C. Tucker, and C. Wu, “Electrical conductivity measurements
using microfabricated interdigitated electrodes,” Analytical Chemistry, vol. 65,
no. 9, pp. 1199–1202, 1993.
[150] G. C. Mendes, T. R. Brandão, and C. L. Silva, “Ethylene oxide sterilization of
medical devices: A review,” American Journal of Infection Control, vol. 35, no. 9,
pp. 574 – 581, 2007.
[151] Y. Yang and J. Jia, “A multi-frequency electrical impedance tomography system
for real-time 2D and 3D imaging,” Review of Scientific Instruments, vol. 88, no. 8,
2017.
[152] A. R. Frangi, P. J. Riu, J. Rosell, and M. A. Viergever, “Propagation of mea-
surement noise through backprojection reconstruction in electrical impedance to-
mography,” IEEE Transactions on Medical Imaging, vol. 21, pp. 566–578, June
2002.
[153] “MCF7 (ATCC® HTB-22™).” https://www.lgcstandards-atcc.org/Products/
All/HTB-22.aspx?geo_country=gb#documentation. Accessed: 2016-09-08.
[154] N. Jamil, S. Smith, Y. Yang, J. Jia, P. Bagnaninchi, and E. Gonzalez-Fernandez,
“Design and fabrication of microelectrodes for electrical impedance tomography
of cell spheroids,” IECBES 2016 - IEEE-EMBS Conference on Biomedical Engi-
neering and Sciences, pp. 426–431, 2017.
BIBLIOGRAPHY
[155] A. Hernández, E. Martró, L. Matas, M. Martín, and V. Ausina, “Assessment of
in-vitro efficacy of 1 % Virkon® against bacteria, fungi, viruses and spores by
means of AFNOR guidelines,” Journal of Hospital Infection, vol. 46, pp. 203–209,
2000.
[156] “DMSO/Sodium Bicarbonate IV Therapy.” http://medicorcancer.com/
dmso-therapy/. Accessed: 2018-17-11.
[157] “Encyclopaedia Britannica, Bacteria-Growth of bacterial populations.” https:
//www.britannica.com/science/bacteria/Growth-of-bacterial-populations. Ac-
cessed: 2018-17-11.
[158] C. C. de Carvalho, “Adaptation of rhodococcus erythropolis cells for growth and
bioremediation under extreme conditions,” Research in Microbiology, vol. 163,
no. 2, pp. 125 – 136, 2012.
